ID

DB08961||

名称

Azosemide

描述

Azosemide is a loop diuretic used to treat hypertension, edema, and ascites.

cas号

27589-33-9

唯一标识码

MR40VT1L8Z

状态

solid

组

investigational,

指示

药效学

Diuretic affects upon oral administration match those of furosemide. However, upon intravenous administration azosemide displays 5.5 to 8 times greater effect.

作用机制

Exact mechanism of action is unclear. However, it acts primarily on the loop of Henle, in both the medullary and cortical segments of the thick ascending limb.

毒性

代谢

Considerable first pass metabolism which makes parentral administration more effective than oral administration. Eleven metabolites of azosemide were found in rats, but only azosemide and its glucuronide were detected in humans.

吸收

Peak plasma concentrations are achieved in 3-4 hours when azosemide is administered to healthy humans in a fasting state. There is an absorption lag time of approximately 1 hour. Oral bioavailability estimated to be 20.4%

半衰期

Terminal half life 2-3 hours.

分类

description:This compound belongs to the class of organic compounds known as phenyltetrazoles and derivatives. These are compounds containing a phenyltetrazole skeleton, which consists of a tetrazole bound to a phenyl group.
direct-parent:Phenyltetrazoles and derivatives
kingdom:Organic compounds
superclass:Organoheterocyclic compounds
class:Azoles
subclass:Tetrazoles
alternative-parent:Aminobenzenesulfonamides
alternative-parent:Aminosulfonyl compounds
alternative-parent:Aniline and substituted anilines
alternative-parent:Aryl chlorides
alternative-parent:Azacyclic compounds
alternative-parent:Benzenesulfonyl compounds
alternative-parent:Chlorobenzenes
alternative-parent:Heteroaromatic compounds
alternative-parent:Hydrocarbon derivatives
alternative-parent:Organic oxides
alternative-parent:Organochlorides
alternative-parent:Organopnictogen compounds
alternative-parent:Organosulfonamides
alternative-parent:Phenylalkylamines
alternative-parent:Secondary alkylarylamines
alternative-parent:Thiophenes
substituent:Amine
substituent:Aminobenzenesulfonamide
substituent:Aminosulfonyl compound
substituent:Aniline or substituted anilines
substituent:Aralkylamine
substituent:Aromatic heteromonocyclic compound
substituent:Aryl chloride
substituent:Aryl halide
substituent:Azacycle
substituent:Benzenesulfonamide
substituent:Benzenesulfonyl group
substituent:Benzenoid
substituent:Chlorobenzene
substituent:Halobenzene
substituent:Heteroaromatic compound
substituent:Hydrocarbon derivative
substituent:Monocyclic benzene moiety
substituent:Organic nitrogen compound
substituent:Organic oxide
substituent:Organic oxygen compound
substituent:Organic sulfonic acid or derivatives
substituent:Organochloride
substituent:Organohalogen compound
substituent:Organonitrogen compound
substituent:Organopnictogen compound
substituent:Organosulfonic acid amide
substituent:Organosulfonic acid or derivatives
substituent:Organosulfur compound
substituent:Phenylalkylamine
substituent:Phenyltetrazole
substituent:Secondary aliphatic/aromatic amine
substituent:Secondary amine
substituent:Sulfonyl
substituent:Thiophene

消除途径

Total body clearance 112ml/min. Renal clearance 41.6ml/min. Actively secreted in the renal proximal tubule of humans. This may or may not involve a nonspecific organic acid secretory pathway. There is thus a potential for disease states and other organic acids such as NSAIDs which affect the organic acid transport pathway to affect the efficacy of azosemide.

种类

Amides
D000577
Amines
D000588
Aniline Compounds
D000814
Cardiovascular Agents
D002317
Diuretics
D004232
Natriuretic Agents
D045283
Sodium Potassium Chloride Symporter Inhibitors
D049994
Sulfonamides
D013449
Sulfones
D013450
Sulfur Compounds
D013457

盐类

蛋白质结合

> 95% 4% protein binding to 4% human serum albumin at azosemide concentrations of 10-100ug/ml, using equilibrium dialysis.

清除

同义词

language:english; code:; name;2-chloro-5-(1H-tetrazol-5-yl)-N4-2-thenylsulfanilamide
language:english; code:; name;5-(4'-chloro-5'-sulfamoyl-2'-thenylaminophenyl)tetrazole
language:spanish; code:inn; name;azosemida
language:english; code:inn; name;Azosemide
language:french; code:inn; name;azosémide
language:latin; code:inn; name;azosemidum

国际品牌

配送量

Poor affinity for human tissue. Small apparent post-pseudodistribution Vd of 0.262 l/kg.

产品

混合物

包装者

生产者

价格

受影响的生物体

剂量

atc代码

fda标签

化学品安全技术说明书

专利

食物相互作用

药物相互作用

DB00437
The risk or severity of adverse effects can be increased when Azosemide is combined with Allopurinol.
DB08907
The risk or severity of hypotension can be increased when Canagliflozin is combined with Azosemide.
DB00515
The risk or severity of ototoxicity and nephrotoxicity can be increased when Azosemide is combined with Cisplatin.
DB00204
The risk or severity of QTc prolongation, torsade de pointes, hypokalemia, hypomagnesemia, and cardiac arrest can be increased when Azosemide is combined with Dofetilide.
DB00529
Azosemide may decrease the excretion rate of Foscarnet which could result in a higher serum level.
DB09083
The risk or severity of Cardiac Arrhythmia can be increased when Azosemide is combined with Ivabradine.
DB14507
Azosemide may decrease the excretion rate of Lithium citrate which could result in a higher serum level.
DB14509
Azosemide may decrease the excretion rate of Lithium carbonate which could result in a higher serum level.
DB14506
Azosemide may decrease the excretion rate of Lithium hydroxide which could result in a higher serum level.
DB00184
The risk or severity of adverse effects can be increased when Azosemide is combined with Nicotine.
DB00657
The risk or severity of adverse effects can be increased when Azosemide is combined with Mecamylamine.
DB01090
The risk or severity of adverse effects can be increased when Azosemide is combined with Pentolinium.
DB01116
The risk or severity of adverse effects can be increased when Azosemide is combined with Trimethaphan.
DB08960
The risk or severity of adverse effects can be increased when Azosemide is combined with Hexamethonium.
DB08999
The risk or severity of adverse effects can be increased when Azosemide is combined with Cyclopentamine.
DB01032
The risk or severity of adverse effects can be increased when Probenecid is combined with Azosemide.
DB00734
The risk or severity of hypotension can be increased when Azosemide is combined with Risperidone.
DB00273
The risk or severity of hypokalemia can be increased when Azosemide is combined with Topiramate.
DB00563
The risk or severity of adverse effects can be increased when Methotrexate is combined with Azosemide.
DB00390
The risk or severity of adverse effects can be increased when Azosemide is combined with Digoxin.
DB00511
The risk or severity of adverse effects can be increased when Azosemide is combined with Acetyldigitoxin.
DB01078
The risk or severity of adverse effects can be increased when Azosemide is combined with Deslanoside.
DB01092
The risk or severity of adverse effects can be increased when Azosemide is combined with Ouabain.
DB01396
The risk or severity of adverse effects can be increased when Azosemide is combined with Digitoxin.
DB12843
The risk or severity of adverse effects can be increased when Azosemide is combined with Oleandrin.
DB13240
The risk or severity of adverse effects can be increased when Azosemide is combined with Cymarin.
DB13307
The risk or severity of adverse effects can be increased when Azosemide is combined with Proscillaridin.
DB13401
The risk or severity of adverse effects can be increased when Azosemide is combined with Metildigoxin.
DB13467
The risk or severity of adverse effects can be increased when Azosemide is combined with Lanatoside C.
DB13537
The risk or severity of adverse effects can be increased when Azosemide is combined with Gitoformate.
DB13691
The risk or severity of adverse effects can be increased when Azosemide is combined with Acetyldigoxin.
DB13756
The risk or severity of adverse effects can be increased when Azosemide is combined with Peruvoside.
DB00159
The therapeutic efficacy of Azosemide can be decreased when used in combination with Icosapent.
DB00244
The therapeutic efficacy of Azosemide can be decreased when used in combination with Mesalazine.
DB00461
The therapeutic efficacy of Azosemide can be decreased when used in combination with Nabumetone.
DB00465
The therapeutic efficacy of Azosemide can be decreased when used in combination with Ketorolac.
DB00469
The therapeutic efficacy of Azosemide can be decreased when used in combination with Tenoxicam.
DB00482
The therapeutic efficacy of Azosemide can be decreased when used in combination with Celecoxib.
DB00500
The therapeutic efficacy of Azosemide can be decreased when used in combination with Tolmetin.
DB00533
The therapeutic efficacy of Azosemide can be decreased when used in combination with Rofecoxib.
DB00554
The therapeutic efficacy of Azosemide can be decreased when used in combination with Piroxicam.
DB00573
The therapeutic efficacy of Azosemide can be decreased when used in combination with Fenoprofen.
DB00580
The therapeutic efficacy of Azosemide can be decreased when used in combination with Valdecoxib.
DB00586
The therapeutic efficacy of Azosemide can be decreased when used in combination with Diclofenac.
DB00605
The therapeutic efficacy of Azosemide can be decreased when used in combination with Sulindac.
DB00712
The therapeutic efficacy of Azosemide can be decreased when used in combination with Flurbiprofen.
DB00749
The therapeutic efficacy of Azosemide can be decreased when used in combination with Etodolac.
DB00784
The therapeutic efficacy of Azosemide can be decreased when used in combination with Mefenamic acid.
DB00788
The therapeutic efficacy of Azosemide can be decreased when used in combination with Naproxen.
DB00795
The therapeutic efficacy of Azosemide can be decreased when used in combination with Sulfasalazine.
DB00812
The therapeutic efficacy of Azosemide can be decreased when used in combination with Phenylbutazone.
DB00821
The therapeutic efficacy of Azosemide can be decreased when used in combination with Carprofen.
DB00861
The therapeutic efficacy of Azosemide can be decreased when used in combination with Diflunisal.
DB00936
The therapeutic efficacy of Azosemide can be decreased when used in combination with Salicylic acid.
DB00939
The therapeutic efficacy of Azosemide can be decreased when used in combination with Meclofenamic acid.
DB00991
The therapeutic efficacy of Azosemide can be decreased when used in combination with Oxaprozin.
DB01009
The therapeutic efficacy of Azosemide can be decreased when used in combination with Ketoprofen.
DB01014
The therapeutic efficacy of Azosemide can be decreased when used in combination with Balsalazide.
DB01050
The therapeutic efficacy of Azosemide can be decreased when used in combination with Ibuprofen.
DB01250
The therapeutic efficacy of Azosemide can be decreased when used in combination with Olsalazine.
DB01283
The therapeutic efficacy of Azosemide can be decreased when used in combination with Lumiracoxib.
DB01397
The therapeutic efficacy of Azosemide can be decreased when used in combination with Magnesium salicylate.
DB01399
The therapeutic efficacy of Azosemide can be decreased when used in combination with Salsalate.
DB01401
The therapeutic efficacy of Azosemide can be decreased when used in combination with Choline magnesium trisalicylate.
DB01419
The therapeutic efficacy of Azosemide can be decreased when used in combination with Antrafenine.
DB01424
The therapeutic efficacy of Azosemide can be decreased when used in combination with Aminophenazone.
DB01435
The therapeutic efficacy of Azosemide can be decreased when used in combination with Antipyrine.
DB01600
The therapeutic efficacy of Azosemide can be decreased when used in combination with Tiaprofenic acid.
DB01628
The therapeutic efficacy of Azosemide can be decreased when used in combination with Etoricoxib.
DB02224
The therapeutic efficacy of Azosemide can be decreased when used in combination with Taxifolin.
DB03585
The therapeutic efficacy of Azosemide can be decreased when used in combination with Oxyphenbutazone.
DB04725
The therapeutic efficacy of Azosemide can be decreased when used in combination with Licofelone.
DB04743
The therapeutic efficacy of Azosemide can be decreased when used in combination with Nimesulide.
DB04812
The therapeutic efficacy of Azosemide can be decreased when used in combination with Benoxaprofen.
DB04817
The therapeutic efficacy of Azosemide can be decreased when used in combination with Metamizole.
DB04828
The therapeutic efficacy of Azosemide can be decreased when used in combination with Zomepirac.
DB05095
The therapeutic efficacy of Azosemide can be decreased when used in combination with Cimicoxib.
DB06725
The therapeutic efficacy of Azosemide can be decreased when used in combination with Lornoxicam.
DB06736
The therapeutic efficacy of Azosemide can be decreased when used in combination with Aceclofenac.
DB06737
The therapeutic efficacy of Azosemide can be decreased when used in combination with Zaltoprofen.
DB07402
The therapeutic efficacy of Azosemide can be decreased when used in combination with Azapropazone.
DB08439
The therapeutic efficacy of Azosemide can be decreased when used in combination with Parecoxib.
DB08797
The therapeutic efficacy of Azosemide can be decreased when used in combination with Salicylamide.
DB08940
The therapeutic efficacy of Azosemide can be decreased when used in combination with Kebuzone.
DB08942
The therapeutic efficacy of Azosemide can be decreased when used in combination with Isoxicam.
DB08951
The therapeutic efficacy of Azosemide can be decreased when used in combination with Indoprofen.
DB08955
The therapeutic efficacy of Azosemide can be decreased when used in combination with Ibuproxam.
DB08976
The therapeutic efficacy of Azosemide can be decreased when used in combination with Floctafenine.
DB08981
The therapeutic efficacy of Azosemide can be decreased when used in combination with Fenbufen.
DB08984
The therapeutic efficacy of Azosemide can be decreased when used in combination with Etofenamate.
DB08991
The therapeutic efficacy of Azosemide can be decreased when used in combination with Epirizole.
DB09084
The therapeutic efficacy of Azosemide can be decreased when used in combination with Benzydamine.
DB09213
The therapeutic efficacy of Azosemide can be decreased when used in combination with Dexibuprofen.
DB09214
The therapeutic efficacy of Azosemide can be decreased when used in combination with Dexketoprofen.
DB09215
The therapeutic efficacy of Azosemide can be decreased when used in combination with Droxicam.
DB09216
The therapeutic efficacy of Azosemide can be decreased when used in combination with Tolfenamic acid.
DB09217
The therapeutic efficacy of Azosemide can be decreased when used in combination with Firocoxib.
DB09218
The therapeutic efficacy of Azosemide can be decreased when used in combination with Clonixin.
DB09285
The therapeutic efficacy of Azosemide can be decreased when used in combination with Morniflumate.
DB09288
The therapeutic efficacy of Azosemide can be decreased when used in combination with Propacetamol.
DB09295
The therapeutic efficacy of Azosemide can be decreased when used in combination with Talniflumate.
DB11455
The therapeutic efficacy of Azosemide can be decreased when used in combination with Robenacoxib.
DB11466
The therapeutic efficacy of Azosemide can be decreased when used in combination with Tepoxalin.
DB11518
The therapeutic efficacy of Azosemide can be decreased when used in combination with Flunixin.
DB12399
The therapeutic efficacy of Azosemide can be decreased when used in combination with Polmacoxib.
DB12445
The therapeutic efficacy of Azosemide can be decreased when used in combination with Nitroaspirin.
DB12545
The therapeutic efficacy of Azosemide can be decreased when used in combination with Indobufen.
DB12610
The therapeutic efficacy of Azosemide can be decreased when used in combination with Ebselen.
DB13001
The therapeutic efficacy of Azosemide can be decreased when used in combination with Tinoridine.
DB13167
The therapeutic efficacy of Azosemide can be decreased when used in combination with Alclofenac.
DB13217
The therapeutic efficacy of Azosemide can be decreased when used in combination with Fentiazac.
DB13232
The therapeutic efficacy of Azosemide can be decreased when used in combination with Suxibuzone.
DB13286
The therapeutic efficacy of Azosemide can be decreased when used in combination with Bumadizone.
DB13314
The therapeutic efficacy of Azosemide can be decreased when used in combination with Alminoprofen.
DB13371
The therapeutic efficacy of Azosemide can be decreased when used in combination with Difenpiramide.
DB13407
The therapeutic efficacy of Azosemide can be decreased when used in combination with Nifenazone.
DB13432
The therapeutic efficacy of Azosemide can be decreased when used in combination with Lonazolac.
DB13481
The therapeutic efficacy of Azosemide can be decreased when used in combination with Tenidap.
DB13524
The therapeutic efficacy of Azosemide can be decreased when used in combination with Propyphenazone.
DB13527
The therapeutic efficacy of Azosemide can be decreased when used in combination with Proglumetacin.
DB13538
The therapeutic efficacy of Azosemide can be decreased when used in combination with Guacetisal.
DB13544
The therapeutic efficacy of Azosemide can be decreased when used in combination with Ethenzamide.
DB13612
The therapeutic efficacy of Azosemide can be decreased when used in combination with Carbaspirin calcium.
DB13629
The therapeutic efficacy of Azosemide can be decreased when used in combination with Mofebutazone.
DB13649
The therapeutic efficacy of Azosemide can be decreased when used in combination with Proquazone.
DB13657
The therapeutic efficacy of Azosemide can be decreased when used in combination with Benorilate.
DB13722
The therapeutic efficacy of Azosemide can be decreased when used in combination with Pirprofen.
DB13860
The therapeutic efficacy of Azosemide can be decreased when used in combination with Imidazole salicylate.
DB14059
The therapeutic efficacy of Azosemide can be decreased when used in combination with SC-236.
DB14060
The therapeutic efficacy of Azosemide can be decreased when used in combination with NS-398.
DB14938
The therapeutic efficacy of Azosemide can be decreased when used in combination with Flurbiprofen axetil.
DB00328
The therapeutic efficacy of Azosemide can be decreased when used in combination with Indomethacin.
DB09212
The therapeutic efficacy of Azosemide can be decreased when used in combination with Loxoprofen.
DB00091
The risk or severity of renal failure can be increased when Cyclosporine is combined with Azosemide.
DB00314
The serum concentration of Capreomycin can be increased when it is combined with Azosemide.
DB00452
The serum concentration of Framycetin can be increased when it is combined with Azosemide.
DB00479
The serum concentration of Amikacin can be increased when it is combined with Azosemide.
DB00684
The serum concentration of Tobramycin can be increased when it is combined with Azosemide.
DB00798
The serum concentration of Gentamicin can be increased when it is combined with Azosemide.
DB00955
The serum concentration of Netilmicin can be increased when it is combined with Azosemide.
DB00994
The serum concentration of Neomycin can be increased when it is combined with Azosemide.
DB01082
The serum concentration of Streptomycin can be increased when it is combined with Azosemide.
DB01172
The serum concentration of Kanamycin can be increased when it is combined with Azosemide.
DB01421
The serum concentration of Paromomycin can be increased when it is combined with Azosemide.
DB03615
The serum concentration of Ribostamycin can be increased when it is combined with Azosemide.
DB04263
The serum concentration of Geneticin can be increased when it is combined with Azosemide.
DB04626
The serum concentration of Apramycin can be increased when it is combined with Azosemide.
DB04729
The serum concentration of Gentamicin C1a can be increased when it is combined with Azosemide.
DB04808
The serum concentration of Neamine can be increased when it is combined with Azosemide.
DB06696
The serum concentration of Arbekacin can be increased when it is combined with Azosemide.
DB08437
The serum concentration of Puromycin can be increased when it is combined with Azosemide.
DB11512
The serum concentration of Dihydrostreptomycin can be increased when it is combined with Azosemide.
DB11520
The serum concentration of Hygromycin B can be increased when it is combined with Azosemide.
DB12604
The serum concentration of Sisomicin can be increased when it is combined with Azosemide.
DB12615
The serum concentration of Plazomicin can be increased when it is combined with Azosemide.
DB13540
The serum concentration of Isepamicin can be increased when it is combined with Azosemide.
DB00803
The serum concentration of Colistin can be increased when it is combined with Azosemide.
DB00233
The risk or severity of adverse effects can be increased when Aminosalicylic acid is combined with Azosemide.
DB01294
The risk or severity of adverse effects can be increased when Bismuth subsalicylate is combined with Azosemide.
DB06251
The risk or severity of adverse effects can be increased when Dersalazine is combined with Azosemide.
DB06807
The risk or severity of adverse effects can be increased when Phenyl aminosalicylate is combined with Azosemide.
DB09543
The risk or severity of adverse effects can be increased when Methyl salicylate is combined with Azosemide.
DB13509
The risk or severity of adverse effects can be increased when Aloxiprin is combined with Azosemide.
DB14026
The risk or severity of adverse effects can be increased when Thiosalicylic acid is combined with Azosemide.
DB14006
The risk or severity of adverse effects can be increased when Azosemide is combined with Choline salicylate.
DB00178
Azosemide may increase the hypotensive activities of Ramipril.
DB00519
Azosemide may increase the hypotensive activities of Trandolapril.
DB00542
Azosemide may increase the hypotensive activities of Benazepril.
DB00584
Azosemide may increase the hypotensive activities of Enalapril.
DB00691
Azosemide may increase the hypotensive activities of Moexipril.
DB00881
Azosemide may increase the hypotensive activities of Quinapril.
DB00886
Azosemide may increase the hypotensive activities of Omapatrilat.
DB01180
Azosemide may increase the hypotensive activities of Rescinnamine.
DB01197
Azosemide may increase the hypotensive activities of Captopril.
DB01340
Azosemide may increase the hypotensive activities of Cilazapril.
DB01348
Azosemide may increase the hypotensive activities of Spirapril.
DB08836
Azosemide may increase the hypotensive activities of Temocapril.
DB11783
Azosemide may increase the hypotensive activities of Imidapril.
DB13166
Azosemide may increase the hypotensive activities of Zofenopril.
DB13312
Azosemide may increase the hypotensive activities of Delapril.
DB14125
Azosemide may increase the hypotensive activities of Benazeprilat.
DB14207
Azosemide may increase the hypotensive activities of Fosinoprilat.
DB14208
Azosemide may increase the hypotensive activities of Ramiprilat.
DB14209
Azosemide may increase the hypotensive activities of Trandolaprilat.
DB14210
Azosemide may increase the hypotensive activities of Moexiprilat.
DB14213
Azosemide may increase the hypotensive activities of Perindoprilat.
DB14217
Azosemide may increase the hypotensive activities of Quinaprilat.
DB14231
Azosemide may increase the hypotensive activities of Quinoline Yellow WS.
DB15565
Azosemide may increase the hypotensive activities of Cilazaprilat.
DB00202
Azosemide may decrease the neuromuscular blocking activities of Succinylcholine.
DB00416
Azosemide may decrease the neuromuscular blocking activities of Metocurine iodide.
DB00483
Azosemide may decrease the neuromuscular blocking activities of Gallamine triethiodide.
DB00565
Azosemide may decrease the neuromuscular blocking activities of Cisatracurium.
DB00728
Azosemide may decrease the neuromuscular blocking activities of Rocuronium.
DB00732
Azosemide may decrease the neuromuscular blocking activities of Atracurium besylate.
DB01135
Azosemide may decrease the neuromuscular blocking activities of Doxacurium.
DB01199
Azosemide may decrease the neuromuscular blocking activities of Tubocurarine.
DB01226
Azosemide may decrease the neuromuscular blocking activities of Mivacurium.
DB01245
Azosemide may decrease the neuromuscular blocking activities of Decamethonium.
DB01336
Azosemide may decrease the neuromuscular blocking activities of Metocurine.
DB01337
Azosemide may decrease the neuromuscular blocking activities of Pancuronium.
DB01338
Azosemide may decrease the neuromuscular blocking activities of Pipecuronium.
DB01339
Azosemide may decrease the neuromuscular blocking activities of Vecuronium.
DB04834
Azosemide may decrease the neuromuscular blocking activities of Rapacuronium.
DB11156
Azosemide may decrease the neuromuscular blocking activities of Pyrantel.
DB12989
Azosemide may decrease the neuromuscular blocking activities of Neosaxitoxin.
DB13295
Azosemide may decrease the neuromuscular blocking activities of Atracurium.
DB13584
Azosemide may decrease the neuromuscular blocking activities of Gallamine.
DB13648
Azosemide may decrease the neuromuscular blocking activities of Alcuronium.
DB00221
The risk or severity of hypokalemia can be increased when Isoetharine is combined with Azosemide.
DB00397
The risk or severity of hypokalemia can be increased when Phenylpropanolamine is combined with Azosemide.
DB00816
The risk or severity of hypokalemia can be increased when Orciprenaline is combined with Azosemide.
DB00841
The risk or severity of hypokalemia can be increased when Dobutamine is combined with Azosemide.
DB00867
The risk or severity of hypokalemia can be increased when Ritodrine is combined with Azosemide.
DB00871
The risk or severity of hypokalemia can be increased when Terbutaline is combined with Azosemide.
DB00901
The risk or severity of hypokalemia can be increased when Bitolterol is combined with Azosemide.
DB00938
The risk or severity of hypokalemia can be increased when Salmeterol is combined with Azosemide.
DB00983
The risk or severity of hypokalemia can be increased when Formoterol is combined with Azosemide.
DB01001
The risk or severity of hypokalemia can be increased when Salbutamol is combined with Azosemide.
DB01064
The risk or severity of hypokalemia can be increased when Isoprenaline is combined with Azosemide.
DB01102
The risk or severity of hypokalemia can be increased when Arbutamine is combined with Azosemide.
DB01274
The risk or severity of hypokalemia can be increased when Arformoterol is combined with Azosemide.
DB01288
The risk or severity of hypokalemia can be increased when Fenoterol is combined with Azosemide.
DB01291
The risk or severity of hypokalemia can be increased when Pirbuterol is combined with Azosemide.
DB01363
The risk or severity of hypokalemia can be increased when Ephedra sinica root is combined with Azosemide.
DB01366
The risk or severity of hypokalemia can be increased when Procaterol is combined with Azosemide.
DB01407
The risk or severity of hypokalemia can be increased when Clenbuterol is combined with Azosemide.
DB01408
The risk or severity of hypokalemia can be increased when Bambuterol is combined with Azosemide.
DB04846
The risk or severity of hypokalemia can be increased when Celiprolol is combined with Azosemide.
DB05039
The risk or severity of hypokalemia can be increased when Indacaterol is combined with Azosemide.
DB08957
The risk or severity of hypokalemia can be increased when Hexoprenaline is combined with Azosemide.
DB09080
The risk or severity of hypokalemia can be increased when Olodaterol is combined with Azosemide.
DB09082
The risk or severity of hypokalemia can be increased when Vilanterol is combined with Azosemide.
DB09273
The risk or severity of hypokalemia can be increased when Doxofylline is combined with Azosemide.
DB11587
The risk or severity of hypokalemia can be increased when Etafedrine is combined with Azosemide.
DB11871
The risk or severity of hypokalemia can be increased when PF-00610355 is combined with Azosemide.
DB12100
The risk or severity of hypokalemia can be increased when Abediterol is combined with Azosemide.
DB12526
The risk or severity of hypokalemia can be increased when Batefenterol is combined with Azosemide.
DB13139
The risk or severity of hypokalemia can be increased when Levosalbutamol is combined with Azosemide.
DB00368
The risk or severity of hypokalemia can be increased when Norepinephrine is combined with Azosemide.
DB00668
The risk or severity of hypokalemia can be increased when Epinephrine is combined with Azosemide.
DB06262
The risk or severity of hypokalemia can be increased when Droxidopa is combined with Azosemide.
DB06814
The risk or severity of hypokalemia can be increased when Protokylol is combined with Azosemide.
DB11124
The risk or severity of hypokalemia can be increased when Racepinephrine is combined with Azosemide.
DB00443
The risk or severity of hypokalemia can be increased when Betamethasone is combined with Azosemide.
DB00588
The risk or severity of hypokalemia can be increased when Fluticasone propionate is combined with Azosemide.
DB00620
The risk or severity of hypokalemia can be increased when Triamcinolone is combined with Azosemide.
DB00687
The risk or severity of hypokalemia can be increased when Fludrocortisone is combined with Azosemide.
DB00741
The risk or severity of hypokalemia can be increased when Hydrocortisone is combined with Azosemide.
DB00860
The risk or severity of hypokalemia can be increased when Prednisolone is combined with Azosemide.
DB00959
The risk or severity of hypokalemia can be increased when Methylprednisolone is combined with Azosemide.
DB01108
The risk or severity of hypokalemia can be increased when Trilostane is combined with Azosemide.
DB01234
The risk or severity of hypokalemia can be increased when Dexamethasone is combined with Azosemide.
DB01285
The risk or severity of hypokalemia can be increased when Corticotropin is combined with Azosemide.
DB01380
The risk or severity of hypokalemia can be increased when Cortisone acetate is combined with Azosemide.
DB01384
The risk or severity of hypokalemia can be increased when Paramethasone is combined with Azosemide.
DB04630
The risk or severity of hypokalemia can be increased when Aldosterone is combined with Azosemide.
DB08970
The risk or severity of hypokalemia can be increased when Fluprednidene is combined with Azosemide.
DB09378
The risk or severity of hypokalemia can be increased when Fluprednisolone is combined with Azosemide.
DB09383
The risk or severity of hypokalemia can be increased when Meprednisone is combined with Azosemide.
DB11487
The risk or severity of hypokalemia can be increased when Dexamethasone isonicotinate is combined with Azosemide.
DB11529
The risk or severity of hypokalemia can be increased when Melengestrol is combined with Azosemide.
DB11921
The risk or severity of hypokalemia can be increased when Deflazacort is combined with Azosemide.
DB13003
The risk or severity of hypokalemia can be increased when Cortivazol is combined with Azosemide.
DB13208
The risk or severity of hypokalemia can be increased when Prednylidene is combined with Azosemide.
DB13223
The risk or severity of hypokalemia can be increased when Fluocortin is combined with Azosemide.
DB13491
The risk or severity of hypokalemia can be increased when Fluperolone is combined with Azosemide.
DB13843
The risk or severity of hypokalemia can be increased when Cloprednol is combined with Azosemide.
DB13856
The risk or severity of hypokalemia can be increased when Fluclorolone is combined with Azosemide.
DB14541
The risk or severity of hypokalemia can be increased when Hydrocortisone cypionate is combined with Azosemide.
DB14545
The risk or severity of hypokalemia can be increased when Hydrocortisone succinate is combined with Azosemide.
DB14631
The risk or severity of hypokalemia can be increased when Prednisolone phosphate is combined with Azosemide.
DB14633
The risk or severity of hypokalemia can be increased when Prednisolone hemisuccinate is combined with Azosemide.
DB14644
The risk or severity of hypokalemia can be increased when Methylprednisolone hemisuccinate is combined with Azosemide.
DB14646
The risk or severity of hypokalemia can be increased when Prednisone acetate is combined with Azosemide.
DB14652
The risk or severity of hypokalemia can be increased when Clocortolone acetate is combined with Azosemide.
DB14659
The risk or severity of hypokalemia can be increased when Melengestrol acetate is combined with Azosemide.
DB14669
The risk or severity of hypokalemia can be increased when Betamethasone phosphate is combined with Azosemide.
DB14681
The risk or severity of hypokalemia can be increased when Cortisone is combined with Azosemide.
DB01013
The risk or severity of hypokalemia can be increased when Clobetasol propionate is combined with Azosemide.
DB01047
The risk or severity of hypokalemia can be increased when Fluocinonide is combined with Azosemide.
DB14512
The risk or severity of hypokalemia can be increased when Mometasone furoate is combined with Azosemide.
DB14540
The risk or severity of hypokalemia can be increased when Hydrocortisone butyrate is combined with Azosemide.
DB01410
The risk or severity of hypokalemia can be increased when Ciclesonide is combined with Azosemide.
DB00547
The risk or severity of hypokalemia can be increased when Desoximetasone is combined with Azosemide.
DB08906
The risk or severity of hypokalemia can be increased when Fluticasone furoate is combined with Azosemide.
DB08971
The risk or severity of hypokalemia can be increased when Fluocortolone is combined with Azosemide.
DB11750
The risk or severity of hypokalemia can be increased when Clobetasol is combined with Azosemide.
DB15566
The risk or severity of hypokalemia can be increased when Prednisolone acetate is combined with Azosemide.
DB00394
The risk or severity of hypokalemia can be increased when Beclomethasone dipropionate is combined with Azosemide.
DB00764
The risk or severity of hypokalemia can be increased when Mometasone is combined with Azosemide.
DB09095
The risk or severity of hypokalemia can be increased when Difluocortolone is combined with Azosemide.
DB09449
Azosemide may increase the nephrotoxic activities of Sodium phosphate, monobasic.
DB13783
The therapeutic efficacy of Azosemide can be decreased when used in combination with Acemetacin.
DB00581
The risk or severity of adverse effects can be increased when Azosemide is combined with Lactulose.
DB00653
The risk or severity of adverse effects can be increased when Azosemide is combined with Magnesium sulfate.
DB00742
The risk or severity of adverse effects can be increased when Azosemide is combined with Mannitol.
DB01046
The risk or severity of adverse effects can be increased when Azosemide is combined with Lubiprostone.
DB01079
The risk or severity of adverse effects can be increased when Azosemide is combined with Tegaserod.
DB01377
The risk or severity of adverse effects can be increased when Azosemide is combined with Magnesium oxide.
DB01378
The risk or severity of adverse effects can be increased when Azosemide is combined with Magnesium cation.
DB01593
The risk or severity of adverse effects can be increased when Azosemide is combined with Zinc.
DB01638
The risk or severity of adverse effects can be increased when Azosemide is combined with Sorbitol.
DB04816
The risk or severity of adverse effects can be increased when Azosemide is combined with Dantron.
DB04823
The risk or severity of adverse effects can be increased when Azosemide is combined with Oxyphenisatin.
DB04824
The risk or severity of adverse effects can be increased when Azosemide is combined with Phenolphthalein.
DB06480
The risk or severity of adverse effects can be increased when Azosemide is combined with Prucalopride.
DB07715
The risk or severity of adverse effects can be increased when Azosemide is combined with Emodin.
DB08890
The risk or severity of adverse effects can be increased when Azosemide is combined with Linaclotide.
DB09020
The risk or severity of adverse effects can be increased when Azosemide is combined with Bisacodyl.
DB09104
The risk or severity of adverse effects can be increased when Azosemide is combined with Magnesium hydroxide.
DB09219
The risk or severity of adverse effects can be increased when Azosemide is combined with Bisoxatin.
DB09268
The risk or severity of adverse effects can be increased when Azosemide is combined with Picosulfuric acid.
DB09281
The risk or severity of adverse effects can be increased when Azosemide is combined with Magnesium trisilicate.
DB09287
The risk or severity of adverse effects can be increased when Azosemide is combined with Polyethylene glycol.
DB09311
The risk or severity of adverse effects can be increased when Azosemide is combined with Polycarbophil.
DB09409
The risk or severity of adverse effects can be increased when Azosemide is combined with Magnesium acetate tetrahydrate.
DB09413
The risk or severity of adverse effects can be increased when Azosemide is combined with Monopotassium phosphate.
DB09414
The risk or severity of adverse effects can be increased when Azosemide is combined with Dipotassium phosphate.
DB09462
The risk or severity of adverse effects can be increased when Azosemide is combined with Glycerin.
DB09472
The risk or severity of adverse effects can be increased when Azosemide is combined with Sodium sulfate.
DB09481
The risk or severity of adverse effects can be increased when Azosemide is combined with Magnesium carbonate.
DB09483
The risk or severity of adverse effects can be increased when Azosemide is combined with Potassium lactate.
DB09484
The risk or severity of adverse effects can be increased when Azosemide is combined with Sodium fluorophosphate.
DB11057
The risk or severity of adverse effects can be increased when Azosemide is combined with Mineral oil.
DB11059
The risk or severity of adverse effects can be increased when Azosemide is combined with Carboxymethylcellulose.
DB11089
The risk or severity of adverse effects can be increased when Azosemide is combined with Docusate.
DB11097
The risk or severity of adverse effects can be increased when Azosemide is combined with Plantago seed.
DB11110
The risk or severity of adverse effects can be increased when Azosemide is combined with Magnesium citrate.
DB11113
The risk or severity of adverse effects can be increased when Azosemide is combined with Castor oil.
DB11189
The risk or severity of adverse effects can be increased when Azosemide is combined with Magnesium glycinate.
DB11228
The risk or severity of adverse effects can be increased when Azosemide is combined with Methylcellulose.
DB11365
The risk or severity of adverse effects can be increased when Azosemide is combined with Sennosides.
DB12942
The risk or severity of adverse effects can be increased when Azosemide is combined with Lactitol.
DB13170
The risk or severity of adverse effects can be increased when Azosemide is combined with Plecanatide.
DB13180
The risk or severity of adverse effects can be increased when Azosemide is combined with Gluconic Acid.
DB13486
The risk or severity of adverse effects can be increased when Azosemide is combined with Magnesium peroxide.
DB13526
The risk or severity of adverse effects can be increased when Azosemide is combined with Pentaerithrityl.
DB13707
The risk or severity of adverse effects can be increased when Azosemide is combined with Sodium tartrate.
DB13996
The risk or severity of adverse effects can be increased when Azosemide is combined with Magnesium acetate.
DB14232
The risk or severity of adverse effects can be increased when Azosemide is combined with Deacetylbisacodyl.
DB14482
The risk or severity of adverse effects can be increased when Azosemide is combined with Sodium ascorbate.
DB14499
The risk or severity of adverse effects can be increased when Azosemide is combined with Potassium sulfate.
DB14502
The risk or severity of adverse effects can be increased when Azosemide is combined with Sodium phosphate, dibasic.
DB14503
The risk or severity of adverse effects can be increased when Azosemide is combined with Sodium phosphate, monobasic, unspecified form.
DB14504
The risk or severity of adverse effects can be increased when Azosemide is combined with Sodium phosphate, dibasic, unspecified form.
DB14516
The risk or severity of adverse effects can be increased when Azosemide is combined with Sodium cation.
DB14585
The risk or severity of adverse effects can be increased when Azosemide is combined with Plantago ovata seed.
DB14627
The risk or severity of adverse effects can be increased when Azosemide is combined with Oxyphenisatin acetate.
DB14684
The risk or severity of adverse effects can be increased when Azosemide is combined with Calcium polycarbophil.
DB14963
The risk or severity of adverse effects can be increased when Azosemide is combined with Konjac mannan.
DB15477
The risk or severity of adverse effects can be increased when Azosemide is combined with Alloin.
DB15478
The risk or severity of adverse effects can be increased when Azosemide is combined with Frangula purshiana bark.
DB11622
The risk or severity of adverse effects can be increased when Azosemide is combined with Dehydrocholic acid.
DB14546
The risk or severity of adverse effects can be increased when Azosemide is combined with Sulfate ion.
DB00030
The therapeutic efficacy of Insulin human can be increased when used in combination with Azosemide.
DB00046
The therapeutic efficacy of Insulin lispro can be increased when used in combination with Azosemide.
DB00047
The therapeutic efficacy of Insulin glargine can be increased when used in combination with Azosemide.
DB00071
The therapeutic efficacy of Insulin pork can be increased when used in combination with Azosemide.
DB00197
The therapeutic efficacy of Troglitazone can be increased when used in combination with Azosemide.
DB00222
The therapeutic efficacy of Glimepiride can be increased when used in combination with Azosemide.
DB00263
The therapeutic efficacy of Sulfisoxazole can be increased when used in combination with Azosemide.
DB00280
The therapeutic efficacy of Disopyramide can be increased when used in combination with Azosemide.
DB00284
The therapeutic efficacy of Acarbose can be increased when used in combination with Azosemide.
DB00331
The therapeutic efficacy of Metformin can be increased when used in combination with Azosemide.
DB00359
The therapeutic efficacy of Sulfadiazine can be increased when used in combination with Azosemide.
DB00412
The therapeutic efficacy of Rosiglitazone can be increased when used in combination with Azosemide.
DB00414
The therapeutic efficacy of Acetohexamide can be increased when used in combination with Azosemide.
DB00468
The therapeutic efficacy of Quinine can be increased when used in combination with Azosemide.
DB00491
The therapeutic efficacy of Miglitol can be increased when used in combination with Azosemide.
DB00672
The therapeutic efficacy of Chlorpropamide can be increased when used in combination with Azosemide.
DB00731
The therapeutic efficacy of Nateglinide can be increased when used in combination with Azosemide.
DB00738
The therapeutic efficacy of Pentamidine can be increased when used in combination with Azosemide.
DB00834
The therapeutic efficacy of Mifepristone can be increased when used in combination with Azosemide.
DB00839
The therapeutic efficacy of Tolazamide can be increased when used in combination with Azosemide.
DB00912
The therapeutic efficacy of Repaglinide can be increased when used in combination with Azosemide.
DB00914
The therapeutic efficacy of Phenformin can be increased when used in combination with Azosemide.
DB01015
The therapeutic efficacy of Sulfamethoxazole can be increased when used in combination with Azosemide.
DB01016
The therapeutic efficacy of Glyburide can be increased when used in combination with Azosemide.
DB01067
The therapeutic efficacy of Glipizide can be increased when used in combination with Azosemide.
DB01120
The therapeutic efficacy of Gliclazide can be increased when used in combination with Azosemide.
DB01124
The therapeutic efficacy of Tolbutamide can be increased when used in combination with Azosemide.
DB01132
The therapeutic efficacy of Pioglitazone can be increased when used in combination with Azosemide.
DB01200
The therapeutic efficacy of Bromocriptine can be increased when used in combination with Azosemide.
DB01251
The therapeutic efficacy of Gliquidone can be increased when used in combination with Azosemide.
DB01252
The therapeutic efficacy of Mitiglinide can be increased when used in combination with Azosemide.
DB01261
The therapeutic efficacy of Sitagliptin can be increased when used in combination with Azosemide.
DB01268
The therapeutic efficacy of Sunitinib can be increased when used in combination with Azosemide.
DB01276
The therapeutic efficacy of Exenatide can be increased when used in combination with Azosemide.
DB01277
The therapeutic efficacy of Mecasermin can be increased when used in combination with Azosemide.
DB01278
The therapeutic efficacy of Pramlintide can be increased when used in combination with Azosemide.
DB01289
The therapeutic efficacy of Glisoxepide can be increased when used in combination with Azosemide.
DB01306
The therapeutic efficacy of Insulin aspart can be increased when used in combination with Azosemide.
DB01307
The therapeutic efficacy of Insulin detemir can be increased when used in combination with Azosemide.
DB01309
The therapeutic efficacy of Insulin glulisine can be increased when used in combination with Azosemide.
DB01382
The therapeutic efficacy of Glymidine can be increased when used in combination with Azosemide.
DB01700
The therapeutic efficacy of AICA ribonucleotide can be increased when used in combination with Azosemide.
DB04830
The therapeutic efficacy of Buformin can be increased when used in combination with Azosemide.
DB04876
The therapeutic efficacy of Vildagliptin can be increased when used in combination with Azosemide.
DB04878
The therapeutic efficacy of Voglibose can be increased when used in combination with Azosemide.
DB05115
The therapeutic efficacy of NN344 can be increased when used in combination with Azosemide.
DB05819
The therapeutic efficacy of NBI-6024 can be increased when used in combination with Azosemide.
DB06011
The therapeutic efficacy of AMG-222 can be increased when used in combination with Azosemide.
DB06127
The therapeutic efficacy of Bisegliptin can be increased when used in combination with Azosemide.
DB06203
The therapeutic efficacy of Alogliptin can be increased when used in combination with Azosemide.
DB06292
The therapeutic efficacy of Dapagliflozin can be increased when used in combination with Azosemide.
DB06335
The therapeutic efficacy of Saxagliptin can be increased when used in combination with Azosemide.
DB06655
The therapeutic efficacy of Liraglutide can be increased when used in combination with Azosemide.
DB08382
The therapeutic efficacy of Gosogliptin can be increased when used in combination with Azosemide.
DB08882
The therapeutic efficacy of Linagliptin can be increased when used in combination with Azosemide.
DB08962
The therapeutic efficacy of Glibornuride can be increased when used in combination with Azosemide.
DB09022
The therapeutic efficacy of Benfluorex can be increased when used in combination with Azosemide.
DB09043
The therapeutic efficacy of Albiglutide can be increased when used in combination with Azosemide.
DB09045
The therapeutic efficacy of Dulaglutide can be increased when used in combination with Azosemide.
DB09198
The therapeutic efficacy of Lobeglitazone can be increased when used in combination with Azosemide.
DB09199
The therapeutic efficacy of Netoglitazone can be increased when used in combination with Azosemide.
DB09200
The therapeutic efficacy of Rivoglitazone can be increased when used in combination with Azosemide.
DB09201
The therapeutic efficacy of Ciglitazone can be increased when used in combination with Azosemide.
DB09265
The therapeutic efficacy of Lixisenatide can be increased when used in combination with Azosemide.
DB09456
The therapeutic efficacy of Insulin beef can be increased when used in combination with Azosemide.
DB09564
The therapeutic efficacy of Insulin degludec can be increased when used in combination with Azosemide.
DB11567
The therapeutic efficacy of Insulin peglispro can be increased when used in combination with Azosemide.
DB11568
The therapeutic efficacy of Insulin tregopil can be increased when used in combination with Azosemide.
DB11698
The therapeutic efficacy of Ipragliflozin can be increased when used in combination with Azosemide.
DB11723
The therapeutic efficacy of Dutogliptin can be increased when used in combination with Azosemide.
DB11780
The therapeutic efficacy of Allicin can be increased when used in combination with Azosemide.
DB11824
The therapeutic efficacy of Tofogliflozin can be increased when used in combination with Azosemide.
DB11827
The therapeutic efficacy of Ertugliflozin can be increased when used in combination with Azosemide.
DB11898
The therapeutic efficacy of 2,4-thiazolidinedione can be increased when used in combination with Azosemide.
DB11950
The therapeutic efficacy of Teneligliptin can be increased when used in combination with Azosemide.
DB11992
The therapeutic efficacy of Omarigliptin can be increased when used in combination with Azosemide.
DB12268
The therapeutic efficacy of Carmegliptin can be increased when used in combination with Azosemide.
DB12412
The therapeutic efficacy of Gemigliptin can be increased when used in combination with Azosemide.
DB12417
The therapeutic efficacy of Anagliptin can be increased when used in combination with Azosemide.
DB12625
The therapeutic efficacy of Evogliptin can be increased when used in combination with Azosemide.
DB12713
The therapeutic efficacy of Sotagliflozin can be increased when used in combination with Azosemide.
DB12781
The therapeutic efficacy of Balaglitazone can be increased when used in combination with Azosemide.
DB12935
The therapeutic efficacy of Remogliflozin etabonate can be increased when used in combination with Azosemide.
DB13406
The therapeutic efficacy of Carbutamide can be increased when used in combination with Azosemide.
DB13446
The therapeutic efficacy of Guar gum can be increased when used in combination with Azosemide.
DB13675
The therapeutic efficacy of Metahexamide can be increased when used in combination with Azosemide.
DB13928
The therapeutic efficacy of Semaglutide can be increased when used in combination with Azosemide.
DB14027
The therapeutic efficacy of Taspoglutide can be increased when used in combination with Azosemide.
DB14035
The therapeutic efficacy of Englitazone can be increased when used in combination with Azosemide.
DB15171
The therapeutic efficacy of Tirzepatide can be increased when used in combination with Azosemide.
DB15217
The therapeutic efficacy of Gastric inhibitory polypeptide can be increased when used in combination with Azosemide.
DB00282
The risk or severity of hypocalcemia can be increased when Azosemide is combined with Pamidronic acid.
DB00399
The risk or severity of hypocalcemia can be increased when Azosemide is combined with Zoledronic acid.
DB00630
The risk or severity of hypocalcemia can be increased when Azosemide is combined with Alendronic acid.
DB00710
The risk or severity of hypocalcemia can be increased when Azosemide is combined with Ibandronate.
DB00720
The risk or severity of hypocalcemia can be increased when Azosemide is combined with Clodronic acid.
DB00884
The risk or severity of hypocalcemia can be increased when Azosemide is combined with Risedronic acid.
DB01077
The risk or severity of hypocalcemia can be increased when Azosemide is combined with Etidronic acid.
DB01133
The risk or severity of hypocalcemia can be increased when Azosemide is combined with Tiludronic acid.
DB06255
The risk or severity of hypocalcemia can be increased when Azosemide is combined with Incadronic acid.
DB00492
Azosemide may increase the excretion rate of Fosinopril which could result in a lower serum level and potentially a reduction in efficacy.
DB00722
Azosemide may increase the excretion rate of Lisinopril which could result in a lower serum level and potentially a reduction in efficacy.
DB00790
Azosemide may increase the excretion rate of Perindopril which could result in a lower serum level and potentially a reduction in efficacy.
DB09477
Azosemide may increase the excretion rate of Enalaprilat which could result in a lower serum level and potentially a reduction in efficacy.
DB00591
Fluocinolone acetonide may increase the excretion rate of Azosemide which could result in a lower serum level and potentially a reduction in efficacy.
DB00635
Prednisone may increase the excretion rate of Azosemide which could result in a lower serum level and potentially a reduction in efficacy.
DB01222
Budesonide may increase the excretion rate of Azosemide which could result in a lower serum level and potentially a reduction in efficacy.
DB09091
Tixocortol may increase the excretion rate of Azosemide which could result in a lower serum level and potentially a reduction in efficacy.
DB01183
Naloxone may increase the excretion rate of Azosemide which could result in a lower serum level and potentially a reduction in efficacy.
DB00007
Azosemide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.
DB00014
Azosemide may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.
DB00017
Azosemide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.
DB00035
Azosemide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.
DB00041
Azosemide may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.
DB00080
Azosemide may increase the excretion rate of Daptomycin which could result in a lower serum level and potentially a reduction in efficacy.
DB00081
Azosemide may increase the excretion rate of Tositumomab which could result in a lower serum level and potentially a reduction in efficacy.
DB00115
Azosemide may increase the excretion rate of Cyanocobalamin which could result in a lower serum level and potentially a reduction in efficacy.
DB00158
Azosemide may increase the excretion rate of Folic acid which could result in a lower serum level and potentially a reduction in efficacy.
DB00165
Azosemide may increase the excretion rate of Pyridoxine which could result in a lower serum level and potentially a reduction in efficacy.
DB00176
Azosemide may increase the excretion rate of Fluvoxamine which could result in a lower serum level and potentially a reduction in efficacy.
DB00181
Azosemide may increase the excretion rate of Baclofen which could result in a lower serum level and potentially a reduction in efficacy.
DB00182
Azosemide may increase the excretion rate of Amphetamine which could result in a lower serum level and potentially a reduction in efficacy.
DB00185
Azosemide may increase the excretion rate of Cevimeline which could result in a lower serum level and potentially a reduction in efficacy.
DB00186
Azosemide may increase the excretion rate of Lorazepam which could result in a lower serum level and potentially a reduction in efficacy.
DB00190
Azosemide may increase the excretion rate of Carbidopa which could result in a lower serum level and potentially a reduction in efficacy.
DB00196
Azosemide may increase the excretion rate of Fluconazole which could result in a lower serum level and potentially a reduction in efficacy.
DB00198
Azosemide may increase the excretion rate of Oseltamivir which could result in a lower serum level and potentially a reduction in efficacy.
DB00200
Azosemide may increase the excretion rate of Hydroxocobalamin which could result in a lower serum level and potentially a reduction in efficacy.
DB00206
Azosemide may increase the excretion rate of Reserpine which could result in a lower serum level and potentially a reduction in efficacy.
DB00208
Azosemide may increase the excretion rate of Ticlopidine which could result in a lower serum level and potentially a reduction in efficacy.
DB00213
Azosemide may increase the excretion rate of Pantoprazole which could result in a lower serum level and potentially a reduction in efficacy.
DB00225
Azosemide may increase the excretion rate of Gadodiamide which could result in a lower serum level and potentially a reduction in efficacy.
DB00230
Azosemide may increase the excretion rate of Pregabalin which could result in a lower serum level and potentially a reduction in efficacy.
DB00231
Azosemide may increase the excretion rate of Temazepam which could result in a lower serum level and potentially a reduction in efficacy.
DB00235
Azosemide may increase the excretion rate of Milrinone which could result in a lower serum level and potentially a reduction in efficacy.
DB00237
Azosemide may increase the excretion rate of Butabarbital which could result in a lower serum level and potentially a reduction in efficacy.
DB00243
Azosemide may increase the excretion rate of Ranolazine which could result in a lower serum level and potentially a reduction in efficacy.
DB00245
Azosemide may increase the excretion rate of Benzatropine which could result in a lower serum level and potentially a reduction in efficacy.
DB00254
Azosemide may increase the excretion rate of Doxycycline which could result in a lower serum level and potentially a reduction in efficacy.
DB00262
Azosemide may increase the excretion rate of Carmustine which could result in a lower serum level and potentially a reduction in efficacy.
DB00264
Azosemide may increase the excretion rate of Metoprolol which could result in a lower serum level and potentially a reduction in efficacy.
DB00270
Azosemide may increase the excretion rate of Isradipine which could result in a lower serum level and potentially a reduction in efficacy.
DB00271
Azosemide may increase the excretion rate of Diatrizoate which could result in a lower serum level and potentially a reduction in efficacy.
DB00279
Azosemide may increase the excretion rate of Liothyronine which could result in a lower serum level and potentially a reduction in efficacy.
DB00285
Azosemide may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy.
DB00286
Azosemide may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.
DB00289
Azosemide may increase the excretion rate of Atomoxetine which could result in a lower serum level and potentially a reduction in efficacy.
DB00290
Azosemide may increase the excretion rate of Bleomycin which could result in a lower serum level and potentially a reduction in efficacy.
DB00292
Azosemide may increase the excretion rate of Etomidate which could result in a lower serum level and potentially a reduction in efficacy.
DB00294
Azosemide may increase the excretion rate of Etonogestrel which could result in a lower serum level and potentially a reduction in efficacy.
DB00296
Azosemide may increase the excretion rate of Ropivacaine which could result in a lower serum level and potentially a reduction in efficacy.
DB00300
Azosemide may increase the excretion rate of Tenofovir disoproxil which could result in a lower serum level and potentially a reduction in efficacy.
DB00303
Azosemide may increase the excretion rate of Ertapenem which could result in a lower serum level and potentially a reduction in efficacy.
DB00308
Azosemide may increase the excretion rate of Ibutilide which could result in a lower serum level and potentially a reduction in efficacy.
DB00312
Azosemide may increase the excretion rate of Pentobarbital which could result in a lower serum level and potentially a reduction in efficacy.
DB00316
Azosemide may increase the excretion rate of Acetaminophen which could result in a lower serum level and potentially a reduction in efficacy.
DB00319
Azosemide may increase the excretion rate of Piperacillin which could result in a lower serum level and potentially a reduction in efficacy.
DB00321
Azosemide may increase the excretion rate of Amitriptyline which could result in a lower serum level and potentially a reduction in efficacy.
DB00322
Azosemide may increase the excretion rate of Floxuridine which could result in a lower serum level and potentially a reduction in efficacy.
DB00323
Azosemide may increase the excretion rate of Tolcapone which could result in a lower serum level and potentially a reduction in efficacy.
DB00325
Azosemide may increase the excretion rate of Nitroprusside which could result in a lower serum level and potentially a reduction in efficacy.
DB00330
Azosemide may increase the excretion rate of Ethambutol which could result in a lower serum level and potentially a reduction in efficacy.
DB00339
Azosemide may increase the excretion rate of Pyrazinamide which could result in a lower serum level and potentially a reduction in efficacy.
DB00341
Azosemide may increase the excretion rate of Cetirizine which could result in a lower serum level and potentially a reduction in efficacy.
DB00349
Azosemide may increase the excretion rate of Clobazam which could result in a lower serum level and potentially a reduction in efficacy.
DB00351
Azosemide may increase the excretion rate of Megestrol acetate which could result in a lower serum level and potentially a reduction in efficacy.
DB00355
Azosemide may increase the excretion rate of Aztreonam which could result in a lower serum level and potentially a reduction in efficacy.
DB00356
Azosemide may increase the excretion rate of Chlorzoxazone which could result in a lower serum level and potentially a reduction in efficacy.
DB00363
Azosemide may increase the excretion rate of Clozapine which could result in a lower serum level and potentially a reduction in efficacy.
DB00364
Azosemide may increase the excretion rate of Sucralfate which could result in a lower serum level and potentially a reduction in efficacy.
DB00369
Azosemide may increase the excretion rate of Cidofovir which could result in a lower serum level and potentially a reduction in efficacy.
DB00372
Azosemide may increase the excretion rate of Thiethylperazine which could result in a lower serum level and potentially a reduction in efficacy.
DB00373
Azosemide may increase the excretion rate of Timolol which could result in a lower serum level and potentially a reduction in efficacy.
DB00377
Azosemide may increase the excretion rate of Palonosetron which could result in a lower serum level and potentially a reduction in efficacy.
DB00380
Azosemide may increase the excretion rate of Dexrazoxane which could result in a lower serum level and potentially a reduction in efficacy.
DB00398
Azosemide may increase the excretion rate of Sorafenib which could result in a lower serum level and potentially a reduction in efficacy.
DB00401
Azosemide may increase the excretion rate of Nisoldipine which could result in a lower serum level and potentially a reduction in efficacy.
DB00402
Azosemide may increase the excretion rate of Eszopiclone which could result in a lower serum level and potentially a reduction in efficacy.
DB00404
Azosemide may increase the excretion rate of Alprazolam which could result in a lower serum level and potentially a reduction in efficacy.
DB00413
Azosemide may increase the excretion rate of Pramipexole which could result in a lower serum level and potentially a reduction in efficacy.
DB00415
Azosemide may increase the excretion rate of Ampicillin which could result in a lower serum level and potentially a reduction in efficacy.
DB00418
Azosemide may increase the excretion rate of Secobarbital which could result in a lower serum level and potentially a reduction in efficacy.
DB00422
Azosemide may increase the excretion rate of Methylphenidate which could result in a lower serum level and potentially a reduction in efficacy.
DB00432
Azosemide may increase the excretion rate of Trifluridine which could result in a lower serum level and potentially a reduction in efficacy.
DB00435
Azosemide may increase the excretion rate of Nitric Oxide which could result in a lower serum level and potentially a reduction in efficacy.
DB00438
Azosemide may increase the excretion rate of Ceftazidime which could result in a lower serum level and potentially a reduction in efficacy.
DB00440
Azosemide may increase the excretion rate of Trimethoprim which could result in a lower serum level and potentially a reduction in efficacy.
DB00441
Azosemide may increase the excretion rate of Gemcitabine which could result in a lower serum level and potentially a reduction in efficacy.
DB00458
Azosemide may increase the excretion rate of Imipramine which could result in a lower serum level and potentially a reduction in efficacy.
DB00476
Azosemide may increase the excretion rate of Duloxetine which could result in a lower serum level and potentially a reduction in efficacy.
DB00477
Azosemide may increase the excretion rate of Chlorpromazine which could result in a lower serum level and potentially a reduction in efficacy.
DB00480
Azosemide may increase the excretion rate of Lenalidomide which could result in a lower serum level and potentially a reduction in efficacy.
DB00490
Azosemide may increase the excretion rate of Buspirone which could result in a lower serum level and potentially a reduction in efficacy.
DB00499
Azosemide may increase the excretion rate of Flutamide which could result in a lower serum level and potentially a reduction in efficacy.
DB00501
Azosemide may increase the excretion rate of Cimetidine which could result in a lower serum level and potentially a reduction in efficacy.
DB00502
Azosemide may increase the excretion rate of Haloperidol which could result in a lower serum level and potentially a reduction in efficacy.
DB00512
Azosemide may increase the excretion rate of Vancomycin which could result in a lower serum level and potentially a reduction in efficacy.
DB00524
Azosemide may increase the excretion rate of Metolazone which could result in a lower serum level and potentially a reduction in efficacy.
DB00535
Azosemide may increase the excretion rate of Cefdinir which could result in a lower serum level and potentially a reduction in efficacy.
DB00537
Azosemide may increase the excretion rate of Ciprofloxacin which could result in a lower serum level and potentially a reduction in efficacy.
DB00548
Azosemide may increase the excretion rate of Azelaic acid which could result in a lower serum level and potentially a reduction in efficacy.
DB00552
Azosemide may increase the excretion rate of Pentostatin which could result in a lower serum level and potentially a reduction in efficacy.
DB00553
Azosemide may increase the excretion rate of Methoxsalen which could result in a lower serum level and potentially a reduction in efficacy.
DB00555
Azosemide may increase the excretion rate of Lamotrigine which could result in a lower serum level and potentially a reduction in efficacy.
DB00558
Azosemide may increase the excretion rate of Zanamivir which could result in a lower serum level and potentially a reduction in efficacy.
DB00564
Azosemide may increase the excretion rate of Carbamazepine which could result in a lower serum level and potentially a reduction in efficacy.
DB00567
Azosemide may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy.
DB00569
Azosemide may increase the excretion rate of Fondaparinux which could result in a lower serum level and potentially a reduction in efficacy.
DB00571
Azosemide may increase the excretion rate of Propranolol which could result in a lower serum level and potentially a reduction in efficacy.
DB00577
Azosemide may increase the excretion rate of Valaciclovir which could result in a lower serum level and potentially a reduction in efficacy.
DB00583
Azosemide may increase the excretion rate of Levocarnitine which could result in a lower serum level and potentially a reduction in efficacy.
DB00597
Azosemide may increase the excretion rate of Gadoteridol which could result in a lower serum level and potentially a reduction in efficacy.
DB00598
Azosemide may increase the excretion rate of Labetalol which could result in a lower serum level and potentially a reduction in efficacy.
DB00603
Azosemide may increase the excretion rate of Medroxyprogesterone acetate which could result in a lower serum level and potentially a reduction in efficacy.
DB00608
Azosemide may increase the excretion rate of Chloroquine which could result in a lower serum level and potentially a reduction in efficacy.
DB00612
Azosemide may increase the excretion rate of Bisoprolol which could result in a lower serum level and potentially a reduction in efficacy.
DB00624
Azosemide may increase the excretion rate of Testosterone which could result in a lower serum level and potentially a reduction in efficacy.
DB00628
Azosemide may increase the excretion rate of Clorazepic acid which could result in a lower serum level and potentially a reduction in efficacy.
DB00631
Azosemide may increase the excretion rate of Clofarabine which could result in a lower serum level and potentially a reduction in efficacy.
DB00633
Azosemide may increase the excretion rate of Dexmedetomidine which could result in a lower serum level and potentially a reduction in efficacy.
DB00642
Azosemide may increase the excretion rate of Pemetrexed which could result in a lower serum level and potentially a reduction in efficacy.
DB00651
Azosemide may increase the excretion rate of Dyphylline which could result in a lower serum level and potentially a reduction in efficacy.
DB00660
Azosemide may increase the excretion rate of Metaxalone which could result in a lower serum level and potentially a reduction in efficacy.
DB00661
Azosemide may increase the excretion rate of Verapamil which could result in a lower serum level and potentially a reduction in efficacy.
DB00665
Azosemide may increase the excretion rate of Nilutamide which could result in a lower serum level and potentially a reduction in efficacy.
DB00669
Azosemide may increase the excretion rate of Sumatriptan which could result in a lower serum level and potentially a reduction in efficacy.
DB00682
Azosemide may increase the excretion rate of Warfarin which could result in a lower serum level and potentially a reduction in efficacy.
DB00683
Azosemide may increase the excretion rate of Midazolam which could result in a lower serum level and potentially a reduction in efficacy.
DB00688
Azosemide may increase the excretion rate of Mycophenolate mofetil which could result in a lower serum level and potentially a reduction in efficacy.
DB00690
Azosemide may increase the excretion rate of Flurazepam which could result in a lower serum level and potentially a reduction in efficacy.
DB00692
Azosemide may increase the excretion rate of Phentolamine which could result in a lower serum level and potentially a reduction in efficacy.
DB00695
Azosemide may increase the excretion rate of Furosemide which could result in a lower serum level and potentially a reduction in efficacy.
DB00698
Azosemide may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.
DB00706
Azosemide may increase the excretion rate of Tamsulosin which could result in a lower serum level and potentially a reduction in efficacy.
DB00709
Azosemide may increase the excretion rate of Lamivudine which could result in a lower serum level and potentially a reduction in efficacy.
DB00713
Azosemide may increase the excretion rate of Oxacillin which could result in a lower serum level and potentially a reduction in efficacy.
DB00716
Azosemide may increase the excretion rate of Nedocromil which could result in a lower serum level and potentially a reduction in efficacy.
DB00730
Azosemide may increase the excretion rate of Thiabendazole which could result in a lower serum level and potentially a reduction in efficacy.
DB00733
Azosemide may increase the excretion rate of Pralidoxime which could result in a lower serum level and potentially a reduction in efficacy.
DB00743
Azosemide may increase the excretion rate of Gadobenic acid which could result in a lower serum level and potentially a reduction in efficacy.
DB00759
Azosemide may increase the excretion rate of Tetracycline which could result in a lower serum level and potentially a reduction in efficacy.
DB00760
Azosemide may increase the excretion rate of Meropenem which could result in a lower serum level and potentially a reduction in efficacy.
DB00761
Azosemide may increase the excretion rate of Potassium chloride which could result in a lower serum level and potentially a reduction in efficacy.
DB00763
Azosemide may increase the excretion rate of Methimazole which could result in a lower serum level and potentially a reduction in efficacy.
DB00775
Azosemide may increase the excretion rate of Tirofiban which could result in a lower serum level and potentially a reduction in efficacy.
DB00780
Azosemide may increase the excretion rate of Phenelzine which could result in a lower serum level and potentially a reduction in efficacy.
DB00782
Azosemide may increase the excretion rate of Propantheline which could result in a lower serum level and potentially a reduction in efficacy.
DB00783
Azosemide may increase the excretion rate of Estradiol which could result in a lower serum level and potentially a reduction in efficacy.
DB00787
Azosemide may increase the excretion rate of Acyclovir which could result in a lower serum level and potentially a reduction in efficacy.
DB00789
Azosemide may increase the excretion rate of Gadopentetic acid which could result in a lower serum level and potentially a reduction in efficacy.
DB00800
Azosemide may increase the excretion rate of Fenoldopam which could result in a lower serum level and potentially a reduction in efficacy.
DB00804
Azosemide may increase the excretion rate of Dicyclomine which could result in a lower serum level and potentially a reduction in efficacy.
DB00806
Azosemide may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.
DB00808
Azosemide may increase the excretion rate of Indapamide which could result in a lower serum level and potentially a reduction in efficacy.
DB00811
Azosemide may increase the excretion rate of Ribavirin which could result in a lower serum level and potentially a reduction in efficacy.
DB00820
Azosemide may increase the excretion rate of Tadalafil which could result in a lower serum level and potentially a reduction in efficacy.
DB00828
Azosemide may increase the excretion rate of Fosfomycin which could result in a lower serum level and potentially a reduction in efficacy.
DB00829
Azosemide may increase the excretion rate of Diazepam which could result in a lower serum level and potentially a reduction in efficacy.
DB00833
Azosemide may increase the excretion rate of Cefaclor which could result in a lower serum level and potentially a reduction in efficacy.
DB00842
Azosemide may increase the excretion rate of Oxazepam which could result in a lower serum level and potentially a reduction in efficacy.
DB00851
Azosemide may increase the excretion rate of Dacarbazine which could result in a lower serum level and potentially a reduction in efficacy.
DB00853
Azosemide may increase the excretion rate of Temozolomide which could result in a lower serum level and potentially a reduction in efficacy.
DB00863
Azosemide may increase the excretion rate of Ranitidine which could result in a lower serum level and potentially a reduction in efficacy.
DB00879
Azosemide may increase the excretion rate of Emtricitabine which could result in a lower serum level and potentially a reduction in efficacy.
DB00887
Azosemide may increase the excretion rate of Bumetanide which could result in a lower serum level and potentially a reduction in efficacy.
DB00894
Azosemide may increase the excretion rate of Testolactone which could result in a lower serum level and potentially a reduction in efficacy.
DB00897
Azosemide may increase the excretion rate of Triazolam which could result in a lower serum level and potentially a reduction in efficacy.
DB00900
Azosemide may increase the excretion rate of Didanosine which could result in a lower serum level and potentially a reduction in efficacy.
DB00908
Azosemide may increase the excretion rate of Quinidine which could result in a lower serum level and potentially a reduction in efficacy.
DB00909
Azosemide may increase the excretion rate of Zonisamide which could result in a lower serum level and potentially a reduction in efficacy.
DB00911
Azosemide may increase the excretion rate of Tinidazole which could result in a lower serum level and potentially a reduction in efficacy.
DB00915
Azosemide may increase the excretion rate of Amantadine which could result in a lower serum level and potentially a reduction in efficacy.
DB00918
Azosemide may increase the excretion rate of Almotriptan which could result in a lower serum level and potentially a reduction in efficacy.
DB00928
Azosemide may increase the excretion rate of Azacitidine which could result in a lower serum level and potentially a reduction in efficacy.
DB00934
Azosemide may increase the excretion rate of Maprotiline which could result in a lower serum level and potentially a reduction in efficacy.
DB00951
Azosemide may increase the excretion rate of Isoniazid which could result in a lower serum level and potentially a reduction in efficacy.
DB00953
Azosemide may increase the excretion rate of Rizatriptan which could result in a lower serum level and potentially a reduction in efficacy.
DB00958
Azosemide may increase the excretion rate of Carboplatin which could result in a lower serum level and potentially a reduction in efficacy.
DB00960
Azosemide may increase the excretion rate of Pindolol which could result in a lower serum level and potentially a reduction in efficacy.
DB00961
Azosemide may increase the excretion rate of Mepivacaine which could result in a lower serum level and potentially a reduction in efficacy.
DB00962
Azosemide may increase the excretion rate of Zaleplon which could result in a lower serum level and potentially a reduction in efficacy.
DB00968
Azosemide may increase the excretion rate of Methyldopa which could result in a lower serum level and potentially a reduction in efficacy.
DB00980
Azosemide may increase the excretion rate of Ramelteon which could result in a lower serum level and potentially a reduction in efficacy.
DB00982
Azosemide may increase the excretion rate of Isotretinoin which could result in a lower serum level and potentially a reduction in efficacy.
DB00988
Azosemide may increase the excretion rate of Dopamine which could result in a lower serum level and potentially a reduction in efficacy.
DB00993
Azosemide may increase the excretion rate of Azathioprine which could result in a lower serum level and potentially a reduction in efficacy.
DB00995
Azosemide may increase the excretion rate of Auranofin which could result in a lower serum level and potentially a reduction in efficacy.
DB01002
Azosemide may increase the excretion rate of Levobupivacaine which could result in a lower serum level and potentially a reduction in efficacy.
DB01004
Azosemide may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy.
DB01010
Azosemide may increase the excretion rate of Edrophonium which could result in a lower serum level and potentially a reduction in efficacy.
DB01011
Azosemide may increase the excretion rate of Metyrapone which could result in a lower serum level and potentially a reduction in efficacy.
DB01018
Azosemide may increase the excretion rate of Guanfacine which could result in a lower serum level and potentially a reduction in efficacy.
DB01020
Azosemide may increase the excretion rate of Isosorbide mononitrate which could result in a lower serum level and potentially a reduction in efficacy.
DB01022
Azosemide may increase the excretion rate of Phylloquinone which could result in a lower serum level and potentially a reduction in efficacy.
DB01024
Azosemide may increase the excretion rate of Mycophenolic acid which could result in a lower serum level and potentially a reduction in efficacy.
DB01030
Azosemide may increase the excretion rate of Topotecan which could result in a lower serum level and potentially a reduction in efficacy.
DB01035
Azosemide may increase the excretion rate of Procainamide which could result in a lower serum level and potentially a reduction in efficacy.
DB01036
Azosemide may increase the excretion rate of Tolterodine which could result in a lower serum level and potentially a reduction in efficacy.
DB01039
Azosemide may increase the excretion rate of Fenofibrate which could result in a lower serum level and potentially a reduction in efficacy.
DB01043
Azosemide may increase the excretion rate of Memantine which could result in a lower serum level and potentially a reduction in efficacy.
DB01048
Azosemide may increase the excretion rate of Abacavir which could result in a lower serum level and potentially a reduction in efficacy.
DB01060
Azosemide may increase the excretion rate of Amoxicillin which could result in a lower serum level and potentially a reduction in efficacy.
DB01068
Azosemide may increase the excretion rate of Clonazepam which could result in a lower serum level and potentially a reduction in efficacy.
DB01069
Azosemide may increase the excretion rate of Promethazine which could result in a lower serum level and potentially a reduction in efficacy.
DB01093
Azosemide may increase the excretion rate of Dimethyl sulfoxide which could result in a lower serum level and potentially a reduction in efficacy.
DB01099
Azosemide may increase the excretion rate of Flucytosine which could result in a lower serum level and potentially a reduction in efficacy.
DB01101
Azosemide may increase the excretion rate of Capecitabine which could result in a lower serum level and potentially a reduction in efficacy.
DB01105
Azosemide may increase the excretion rate of Sibutramine which could result in a lower serum level and potentially a reduction in efficacy.
DB01115
Azosemide may increase the excretion rate of Nifedipine which could result in a lower serum level and potentially a reduction in efficacy.
DB01129
Azosemide may increase the excretion rate of Rabeprazole which could result in a lower serum level and potentially a reduction in efficacy.
DB01137
Azosemide may increase the excretion rate of Levofloxacin which could result in a lower serum level and potentially a reduction in efficacy.
DB01140
Azosemide may increase the excretion rate of Cefadroxil which could result in a lower serum level and potentially a reduction in efficacy.
DB01142
Azosemide may increase the excretion rate of Doxepin which could result in a lower serum level and potentially a reduction in efficacy.
DB01148
Azosemide may increase the excretion rate of Flavoxate which could result in a lower serum level and potentially a reduction in efficacy.
DB01149
Azosemide may increase the excretion rate of Nefazodone which could result in a lower serum level and potentially a reduction in efficacy.
DB01151
Azosemide may increase the excretion rate of Desipramine which could result in a lower serum level and potentially a reduction in efficacy.
DB01156
Azosemide may increase the excretion rate of Bupropion which could result in a lower serum level and potentially a reduction in efficacy.
DB01157
Azosemide may increase the excretion rate of Trimetrexate which could result in a lower serum level and potentially a reduction in efficacy.
DB01166
Azosemide may increase the excretion rate of Cilostazol which could result in a lower serum level and potentially a reduction in efficacy.
DB01169
Azosemide may increase the excretion rate of Arsenic trioxide which could result in a lower serum level and potentially a reduction in efficacy.
DB01170
Azosemide may increase the excretion rate of Guanethidine which could result in a lower serum level and potentially a reduction in efficacy.
DB01181
Azosemide may increase the excretion rate of Ifosfamide which could result in a lower serum level and potentially a reduction in efficacy.
DB01203
Azosemide may increase the excretion rate of Nadolol which could result in a lower serum level and potentially a reduction in efficacy.
DB01205
Azosemide may increase the excretion rate of Flumazenil which could result in a lower serum level and potentially a reduction in efficacy.
DB01212
Azosemide may increase the excretion rate of Ceftriaxone which could result in a lower serum level and potentially a reduction in efficacy.
DB01213
Azosemide may increase the excretion rate of Fomepizole which could result in a lower serum level and potentially a reduction in efficacy.
DB01215
Azosemide may increase the excretion rate of Estazolam which could result in a lower serum level and potentially a reduction in efficacy.
DB01221
Azosemide may increase the excretion rate of Ketamine which could result in a lower serum level and potentially a reduction in efficacy.
DB01224
Azosemide may increase the excretion rate of Quetiapine which could result in a lower serum level and potentially a reduction in efficacy.
DB01233
Azosemide may increase the excretion rate of Metoclopramide which could result in a lower serum level and potentially a reduction in efficacy.
DB01240
Azosemide may increase the excretion rate of Epoprostenol which could result in a lower serum level and potentially a reduction in efficacy.
DB01241
Azosemide may increase the excretion rate of Gemfibrozil which could result in a lower serum level and potentially a reduction in efficacy.
DB01242
Azosemide may increase the excretion rate of Clomipramine which could result in a lower serum level and potentially a reduction in efficacy.
DB01249
Azosemide may increase the excretion rate of Iodixanol which could result in a lower serum level and potentially a reduction in efficacy.
DB01267
Azosemide may increase the excretion rate of Paliperidone which could result in a lower serum level and potentially a reduction in efficacy.
DB01273
Azosemide may increase the excretion rate of Varenicline which could result in a lower serum level and potentially a reduction in efficacy.
DB01275
Azosemide may increase the excretion rate of Hydralazine which could result in a lower serum level and potentially a reduction in efficacy.
DB01330
Azosemide may increase the excretion rate of Cefotetan which could result in a lower serum level and potentially a reduction in efficacy.
DB01333
Azosemide may increase the excretion rate of Cefradine which could result in a lower serum level and potentially a reduction in efficacy.
DB01359
Azosemide may increase the excretion rate of Penbutolol which could result in a lower serum level and potentially a reduction in efficacy.
DB01367
Azosemide may increase the excretion rate of Rasagiline which could result in a lower serum level and potentially a reduction in efficacy.
DB01394
Azosemide may increase the excretion rate of Colchicine which could result in a lower serum level and potentially a reduction in efficacy.
DB01409
Azosemide may increase the excretion rate of Tiotropium which could result in a lower serum level and potentially a reduction in efficacy.
DB01415
Azosemide may increase the excretion rate of Ceftibuten which could result in a lower serum level and potentially a reduction in efficacy.
DB01420
Azosemide may increase the excretion rate of Testosterone propionate which could result in a lower serum level and potentially a reduction in efficacy.
DB01427
Azosemide may increase the excretion rate of Amrinone which could result in a lower serum level and potentially a reduction in efficacy.
DB01428
Azosemide may increase the excretion rate of Oxybenzone which could result in a lower serum level and potentially a reduction in efficacy.
DB01431
Azosemide may increase the excretion rate of Allylestrenol which could result in a lower serum level and potentially a reduction in efficacy.
DB01550
Azosemide may increase the excretion rate of Fenproporex which could result in a lower serum level and potentially a reduction in efficacy.
DB01558
Azosemide may increase the excretion rate of Bromazepam which could result in a lower serum level and potentially a reduction in efficacy.
DB01563
Azosemide may increase the excretion rate of Chloral hydrate which could result in a lower serum level and potentially a reduction in efficacy.
DB01577
Azosemide may increase the excretion rate of Metamfetamine which could result in a lower serum level and potentially a reduction in efficacy.
DB01587
Azosemide may increase the excretion rate of Ketazolam which could result in a lower serum level and potentially a reduction in efficacy.
DB01610
Azosemide may increase the excretion rate of Valganciclovir which could result in a lower serum level and potentially a reduction in efficacy.
DB01656
Azosemide may increase the excretion rate of Roflumilast which could result in a lower serum level and potentially a reduction in efficacy.
DB01685
Azosemide may increase the excretion rate of Topiroxostat which could result in a lower serum level and potentially a reduction in efficacy.
DB04574
Azosemide may increase the excretion rate of Estrone sulfate which could result in a lower serum level and potentially a reduction in efficacy.
DB04871
Azosemide may increase the excretion rate of Lorcaserin which could result in a lower serum level and potentially a reduction in efficacy.
DB04895
Azosemide may increase the excretion rate of Pegaptanib which could result in a lower serum level and potentially a reduction in efficacy.
DB04896
Azosemide may increase the excretion rate of Milnacipran which could result in a lower serum level and potentially a reduction in efficacy.
DB04920
Azosemide may increase the excretion rate of Clevidipine which could result in a lower serum level and potentially a reduction in efficacy.
DB04948
Azosemide may increase the excretion rate of Lofexidine which could result in a lower serum level and potentially a reduction in efficacy.
DB04953
Azosemide may increase the excretion rate of Ezogabine which could result in a lower serum level and potentially a reduction in efficacy.
DB05018
Azosemide may increase the excretion rate of Migalastat which could result in a lower serum level and potentially a reduction in efficacy.
DB05541
Azosemide may increase the excretion rate of Brivaracetam which could result in a lower serum level and potentially a reduction in efficacy.
DB05676
Azosemide may increase the excretion rate of Apremilast which could result in a lower serum level and potentially a reduction in efficacy.
DB06154
Azosemide may increase the excretion rate of Pentaerythritol tetranitrate which could result in a lower serum level and potentially a reduction in efficacy.
DB06186
Azosemide may increase the excretion rate of Ipilimumab which could result in a lower serum level and potentially a reduction in efficacy.
DB06196
Azosemide may increase the excretion rate of Icatibant which could result in a lower serum level and potentially a reduction in efficacy.
DB06209
Azosemide may increase the excretion rate of Prasugrel which could result in a lower serum level and potentially a reduction in efficacy.
DB06211
Azosemide may increase the excretion rate of Doripenem which could result in a lower serum level and potentially a reduction in efficacy.
DB06228
Azosemide may increase the excretion rate of Rivaroxaban which could result in a lower serum level and potentially a reduction in efficacy.
DB06230
Azosemide may increase the excretion rate of Nalmefene which could result in a lower serum level and potentially a reduction in efficacy.
DB06282
Azosemide may increase the excretion rate of Levocetirizine which could result in a lower serum level and potentially a reduction in efficacy.
DB06402
Azosemide may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.
DB06623
Azosemide may increase the excretion rate of Flupirtine which could result in a lower serum level and potentially a reduction in efficacy.
DB06637
Azosemide may increase the excretion rate of Dalfampridine which could result in a lower serum level and potentially a reduction in efficacy.
DB06695
Azosemide may increase the excretion rate of Dabigatran etexilate which could result in a lower serum level and potentially a reduction in efficacy.
DB06700
Azosemide may increase the excretion rate of Desvenlafaxine which could result in a lower serum level and potentially a reduction in efficacy.
DB06702
Azosemide may increase the excretion rate of Fesoterodine which could result in a lower serum level and potentially a reduction in efficacy.
DB06705
Azosemide may increase the excretion rate of Gadofosveset trisodium which could result in a lower serum level and potentially a reduction in efficacy.
DB06710
Azosemide may increase the excretion rate of Methyltestosterone which could result in a lower serum level and potentially a reduction in efficacy.
DB06767
Azosemide may increase the excretion rate of Ammonium chloride which could result in a lower serum level and potentially a reduction in efficacy.
DB06782
Azosemide may increase the excretion rate of Dimercaprol which could result in a lower serum level and potentially a reduction in efficacy.
DB06796
Azosemide may increase the excretion rate of Mangafodipir which could result in a lower serum level and potentially a reduction in efficacy.
DB06800
Azosemide may increase the excretion rate of Methylnaltrexone which could result in a lower serum level and potentially a reduction in efficacy.
DB06809
Azosemide may increase the excretion rate of Plerixafor which could result in a lower serum level and potentially a reduction in efficacy.
DB06813
Azosemide may increase the excretion rate of Pralatrexate which could result in a lower serum level and potentially a reduction in efficacy.
DB06823
Azosemide may increase the excretion rate of Tiopronin which could result in a lower serum level and potentially a reduction in efficacy.
DB06824
Azosemide may increase the excretion rate of Triethylenetetramine which could result in a lower serum level and potentially a reduction in efficacy.
DB08824
Azosemide may increase the excretion rate of Ioflupane I-123 which could result in a lower serum level and potentially a reduction in efficacy.
DB08826
Azosemide may increase the excretion rate of Deferiprone which could result in a lower serum level and potentially a reduction in efficacy.
DB08840
Azosemide may increase the excretion rate of N-methylnicotinamide which could result in a lower serum level and potentially a reduction in efficacy.
DB08872
Azosemide may increase the excretion rate of Gabapentin enacarbil which could result in a lower serum level and potentially a reduction in efficacy.
DB08877
Azosemide may increase the excretion rate of Ruxolitinib which could result in a lower serum level and potentially a reduction in efficacy.
DB08893
Azosemide may increase the excretion rate of Mirabegron which could result in a lower serum level and potentially a reduction in efficacy.
DB08894
Azosemide may increase the excretion rate of Peginesatide which could result in a lower serum level and potentially a reduction in efficacy.
DB08897
Azosemide may increase the excretion rate of Aclidinium which could result in a lower serum level and potentially a reduction in efficacy.
DB08899
Azosemide may increase the excretion rate of Enzalutamide which could result in a lower serum level and potentially a reduction in efficacy.
DB08900
Azosemide may increase the excretion rate of Teduglutide which could result in a lower serum level and potentially a reduction in efficacy.
DB08904
Azosemide may increase the excretion rate of Certolizumab pegol which could result in a lower serum level and potentially a reduction in efficacy.
DB08905
Azosemide may increase the excretion rate of Formestane which could result in a lower serum level and potentially a reduction in efficacy.
DB08909
Azosemide may increase the excretion rate of Glycerol phenylbutyrate which could result in a lower serum level and potentially a reduction in efficacy.
DB08910
Azosemide may increase the excretion rate of Pomalidomide which could result in a lower serum level and potentially a reduction in efficacy.
DB08911
Azosemide may increase the excretion rate of Trametinib which could result in a lower serum level and potentially a reduction in efficacy.
DB08918
Azosemide may increase the excretion rate of Levomilnacipran which could result in a lower serum level and potentially a reduction in efficacy.
DB08932
Azosemide may increase the excretion rate of Macitentan which could result in a lower serum level and potentially a reduction in efficacy.
DB08934
Azosemide may increase the excretion rate of Sofosbuvir which could result in a lower serum level and potentially a reduction in efficacy.
DB08996
Azosemide may increase the excretion rate of Dimetacrine which could result in a lower serum level and potentially a reduction in efficacy.
DB09027
Azosemide may increase the excretion rate of Ledipasvir which could result in a lower serum level and potentially a reduction in efficacy.
DB09050
Azosemide may increase the excretion rate of Ceftolozane which could result in a lower serum level and potentially a reduction in efficacy.
DB09066
Azosemide may increase the excretion rate of Corifollitropin alfa which could result in a lower serum level and potentially a reduction in efficacy.
DB09068
Azosemide may increase the excretion rate of Vortioxetine which could result in a lower serum level and potentially a reduction in efficacy.
DB09071
Azosemide may increase the excretion rate of Tasimelteon which could result in a lower serum level and potentially a reduction in efficacy.
DB09075
Azosemide may increase the excretion rate of Edoxaban which could result in a lower serum level and potentially a reduction in efficacy.
DB09081
Azosemide may increase the excretion rate of Idebenone which could result in a lower serum level and potentially a reduction in efficacy.
DB09089
Azosemide may increase the excretion rate of Trimebutine which could result in a lower serum level and potentially a reduction in efficacy.
DB09103
Azosemide may increase the excretion rate of Ancestim which could result in a lower serum level and potentially a reduction in efficacy.
DB09106
Azosemide may increase the excretion rate of Hydroxyethyl Starch which could result in a lower serum level and potentially a reduction in efficacy.
DB09111
Azosemide may increase the excretion rate of Pentastarch which could result in a lower serum level and potentially a reduction in efficacy.
DB09118
Azosemide may increase the excretion rate of Stiripentol which could result in a lower serum level and potentially a reduction in efficacy.
DB09121
Azosemide may increase the excretion rate of Aurothioglucose which could result in a lower serum level and potentially a reduction in efficacy.
DB09123
Azosemide may increase the excretion rate of Dienogest which could result in a lower serum level and potentially a reduction in efficacy.
DB09129
Azosemide may increase the excretion rate of Chromic chloride which could result in a lower serum level and potentially a reduction in efficacy.
DB09132
Azosemide may increase the excretion rate of Gadoteric acid which could result in a lower serum level and potentially a reduction in efficacy.
DB09133
Azosemide may increase the excretion rate of Iothalamic acid which could result in a lower serum level and potentially a reduction in efficacy.
DB09134
Azosemide may increase the excretion rate of Ioversol which could result in a lower serum level and potentially a reduction in efficacy.
DB09135
Azosemide may increase the excretion rate of Ioxilan which could result in a lower serum level and potentially a reduction in efficacy.
DB09136
Azosemide may increase the excretion rate of Isosulfan blue which could result in a lower serum level and potentially a reduction in efficacy.
DB09137
Azosemide may increase the excretion rate of Technetium Tc-99m mebrofenin which could result in a lower serum level and potentially a reduction in efficacy.
DB09139
Azosemide may increase the excretion rate of Technetium Tc-99m oxidronate which could result in a lower serum level and potentially a reduction in efficacy.
DB09148
Azosemide may increase the excretion rate of Florbetaben (18F) which could result in a lower serum level and potentially a reduction in efficacy.
DB09149
Azosemide may increase the excretion rate of Florbetapir (18F) which could result in a lower serum level and potentially a reduction in efficacy.
DB09156
Azosemide may increase the excretion rate of Iopromide which could result in a lower serum level and potentially a reduction in efficacy.
DB09163
Azosemide may increase the excretion rate of Technetium Tc-99m exametazime which could result in a lower serum level and potentially a reduction in efficacy.
DB09165
Azosemide may increase the excretion rate of Technetium Tc-99m pyrophosphate which could result in a lower serum level and potentially a reduction in efficacy.
DB09185
Azosemide may increase the excretion rate of Viloxazine which could result in a lower serum level and potentially a reduction in efficacy.
DB09194
Azosemide may increase the excretion rate of Etoperidone which could result in a lower serum level and potentially a reduction in efficacy.
DB09195
Azosemide may increase the excretion rate of Lorpiprazole which could result in a lower serum level and potentially a reduction in efficacy.
DB09204
Azosemide may increase the excretion rate of Arotinolol which could result in a lower serum level and potentially a reduction in efficacy.
DB09205
Azosemide may increase the excretion rate of Moxisylyte which could result in a lower serum level and potentially a reduction in efficacy.
DB09209
Azosemide may increase the excretion rate of Pholcodine which could result in a lower serum level and potentially a reduction in efficacy.
DB09210
Azosemide may increase the excretion rate of Piracetam which could result in a lower serum level and potentially a reduction in efficacy.
DB09220
Azosemide may increase the excretion rate of Nicorandil which could result in a lower serum level and potentially a reduction in efficacy.
DB09223
Azosemide may increase the excretion rate of Blonanserin which could result in a lower serum level and potentially a reduction in efficacy.
DB09224
Azosemide may increase the excretion rate of Melperone which could result in a lower serum level and potentially a reduction in efficacy.
DB09241
Azosemide may increase the excretion rate of Methylene blue which could result in a lower serum level and potentially a reduction in efficacy.
DB09244
Azosemide may increase the excretion rate of Pirlindole which could result in a lower serum level and potentially a reduction in efficacy.
DB09245
Azosemide may increase the excretion rate of Toloxatone which could result in a lower serum level and potentially a reduction in efficacy.
DB09255
Azosemide may increase the excretion rate of Dextran which could result in a lower serum level and potentially a reduction in efficacy.
DB09256
Azosemide may increase the excretion rate of Tegafur which could result in a lower serum level and potentially a reduction in efficacy.
DB09257
Azosemide may increase the excretion rate of Gimeracil which could result in a lower serum level and potentially a reduction in efficacy.
DB09262
Azosemide may increase the excretion rate of Imidafenacin which could result in a lower serum level and potentially a reduction in efficacy.
DB09264
Azosemide may increase the excretion rate of Idarucizumab which could result in a lower serum level and potentially a reduction in efficacy.
DB09276
Azosemide may increase the excretion rate of Sodium aurothiomalate which could result in a lower serum level and potentially a reduction in efficacy.
DB09277
Azosemide may increase the excretion rate of Choline C 11 which could result in a lower serum level and potentially a reduction in efficacy.
DB09292
Azosemide may increase the excretion rate of Sacubitril which could result in a lower serum level and potentially a reduction in efficacy.
DB09301
Azosemide may increase the excretion rate of Chondroitin sulfate which could result in a lower serum level and potentially a reduction in efficacy.
DB09317
Azosemide may increase the excretion rate of Synthetic Conjugated Estrogens, A which could result in a lower serum level and potentially a reduction in efficacy.
DB09318
Azosemide may increase the excretion rate of Synthetic Conjugated Estrogens, B which could result in a lower serum level and potentially a reduction in efficacy.
DB09320
Azosemide may increase the excretion rate of Procaine benzylpenicillin which could result in a lower serum level and potentially a reduction in efficacy.
DB09324
Azosemide may increase the excretion rate of Sulbactam which could result in a lower serum level and potentially a reduction in efficacy.
DB09325
Azosemide may increase the excretion rate of Sodium fluoride which could result in a lower serum level and potentially a reduction in efficacy.
DB09329
Azosemide may increase the excretion rate of Antihemophilic Factor (Recombinant), PEGylated which could result in a lower serum level and potentially a reduction in efficacy.
DB09338
Azosemide may increase the excretion rate of Mersalyl which could result in a lower serum level and potentially a reduction in efficacy.
DB09344
Azosemide may increase the excretion rate of Invert sugar which could result in a lower serum level and potentially a reduction in efficacy.
DB09357
Azosemide may increase the excretion rate of Dexpanthenol which could result in a lower serum level and potentially a reduction in efficacy.
DB09394
Azosemide may increase the excretion rate of Phosphoric acid which could result in a lower serum level and potentially a reduction in efficacy.
DB09395
Azosemide may increase the excretion rate of Sodium acetate which could result in a lower serum level and potentially a reduction in efficacy.
DB09407
Azosemide may increase the excretion rate of Magnesium chloride which could result in a lower serum level and potentially a reduction in efficacy.
DB09418
Azosemide may increase the excretion rate of Potassium perchlorate which could result in a lower serum level and potentially a reduction in efficacy.
DB09488
Azosemide may increase the excretion rate of Acrivastine which could result in a lower serum level and potentially a reduction in efficacy.
DB09496
Azosemide may increase the excretion rate of Octinoxate which could result in a lower serum level and potentially a reduction in efficacy.
DB09502
Azosemide may increase the excretion rate of Fludeoxyglucose (18F) which could result in a lower serum level and potentially a reduction in efficacy.
DB09546
Azosemide may increase the excretion rate of Iobenguane sulfate I-123 which could result in a lower serum level and potentially a reduction in efficacy.
DB09570
Azosemide may increase the excretion rate of Ixazomib which could result in a lower serum level and potentially a reduction in efficacy.
DB11077
Azosemide may increase the excretion rate of Polyethylene glycol 400 which could result in a lower serum level and potentially a reduction in efficacy.
DB11098
Azosemide may increase the excretion rate of Potassium bicarbonate which could result in a lower serum level and potentially a reduction in efficacy.
DB11102
Azosemide may increase the excretion rate of N-acetyltyrosine which could result in a lower serum level and potentially a reduction in efficacy.
DB11114
Azosemide may increase the excretion rate of Eucalyptus oil which could result in a lower serum level and potentially a reduction in efficacy.
DB11127
Azosemide may increase the excretion rate of Selenious acid which could result in a lower serum level and potentially a reduction in efficacy.
DB11135
Azosemide may increase the excretion rate of Selenium which could result in a lower serum level and potentially a reduction in efficacy.
DB11136
Azosemide may increase the excretion rate of Chromium which could result in a lower serum level and potentially a reduction in efficacy.
DB11145
Azosemide may increase the excretion rate of Oxyquinoline which could result in a lower serum level and potentially a reduction in efficacy.
DB11164
Azosemide may increase the excretion rate of Bicisate which could result in a lower serum level and potentially a reduction in efficacy.
DB11251
Azosemide may increase the excretion rate of Tocopherol which could result in a lower serum level and potentially a reduction in efficacy.
DB11278
Azosemide may increase the excretion rate of DL-Methylephedrine which could result in a lower serum level and potentially a reduction in efficacy.
DB11328
Azosemide may increase the excretion rate of Tetradecyl hydrogen sulfate (ester) which could result in a lower serum level and potentially a reduction in efficacy.
DB11338
Azosemide may increase the excretion rate of Clove oil which could result in a lower serum level and potentially a reduction in efficacy.
DB11358
Azosemide may increase the excretion rate of Evening primrose oil which could result in a lower serum level and potentially a reduction in efficacy.
DB11364
Azosemide may increase the excretion rate of Pidotimod which could result in a lower serum level and potentially a reduction in efficacy.
DB11367
Azosemide may increase the excretion rate of Cefroxadine which could result in a lower serum level and potentially a reduction in efficacy.
DB11560
Azosemide may increase the excretion rate of Lesinurad which could result in a lower serum level and potentially a reduction in efficacy.
DB11577
Azosemide may increase the excretion rate of Indigotindisulfonic acid which could result in a lower serum level and potentially a reduction in efficacy.
DB11598
Azosemide may increase the excretion rate of Antithrombin III human which could result in a lower serum level and potentially a reduction in efficacy.
DB11642
Azosemide may increase the excretion rate of Pitolisant which could result in a lower serum level and potentially a reduction in efficacy.
DB11691
Azosemide may increase the excretion rate of Naldemedine which could result in a lower serum level and potentially a reduction in efficacy.
DB11699
Azosemide may increase the excretion rate of Tropisetron which could result in a lower serum level and potentially a reduction in efficacy.
DB11817
Azosemide may increase the excretion rate of Baricitinib which could result in a lower serum level and potentially a reduction in efficacy.
DB11901
Azosemide may increase the excretion rate of Apalutamide which could result in a lower serum level and potentially a reduction in efficacy.
DB11915
Azosemide may increase the excretion rate of Valbenazine which could result in a lower serum level and potentially a reduction in efficacy.
DB11943
Azosemide may increase the excretion rate of Delafloxacin which could result in a lower serum level and potentially a reduction in efficacy.
DB11989
Azosemide may increase the excretion rate of Benznidazole which could result in a lower serum level and potentially a reduction in efficacy.
DB12007
Azosemide may increase the excretion rate of Isoflavone which could result in a lower serum level and potentially a reduction in efficacy.
DB12107
Azosemide may increase the excretion rate of Vaborbactam which could result in a lower serum level and potentially a reduction in efficacy.
DB12151
Azosemide may increase the excretion rate of Brincidofovir which could result in a lower serum level and potentially a reduction in efficacy.
DB12161
Azosemide may increase the excretion rate of Deutetrabenazine which could result in a lower serum level and potentially a reduction in efficacy.
DB12278
Azosemide may increase the excretion rate of Propiverine which could result in a lower serum level and potentially a reduction in efficacy.
DB12783
Azosemide may increase the excretion rate of Benserazide which could result in a lower serum level and potentially a reduction in efficacy.
DB13025
Azosemide may increase the excretion rate of Tiapride which could result in a lower serum level and potentially a reduction in efficacy.
DB13145
Azosemide may increase the excretion rate of Nedaplatin which could result in a lower serum level and potentially a reduction in efficacy.
DB13156
Azosemide may increase the excretion rate of Inosine pranobex which could result in a lower serum level and potentially a reduction in efficacy.
DB13178
Azosemide may increase the excretion rate of Inositol which could result in a lower serum level and potentially a reduction in efficacy.
DB13185
Azosemide may increase the excretion rate of Oxabolone cipionate which could result in a lower serum level and potentially a reduction in efficacy.
DB13191
Azosemide may increase the excretion rate of Phosphocreatine which could result in a lower serum level and potentially a reduction in efficacy.
DB13269
Azosemide may increase the excretion rate of Dichlorobenzyl alcohol which could result in a lower serum level and potentially a reduction in efficacy.
DB13293
Azosemide may increase the excretion rate of Ipecac which could result in a lower serum level and potentially a reduction in efficacy.
DB13595
Azosemide may increase the excretion rate of Almasilate which could result in a lower serum level and potentially a reduction in efficacy.
DB13873
Azosemide may increase the excretion rate of Fenofibric acid which could result in a lower serum level and potentially a reduction in efficacy.
DB13884
Azosemide may increase the excretion rate of Albutrepenonacog alfa which could result in a lower serum level and potentially a reduction in efficacy.
DB13909
Azosemide may increase the excretion rate of Bismuth subgallate which could result in a lower serum level and potentially a reduction in efficacy.
DB13943
Azosemide may increase the excretion rate of Testosterone cypionate which could result in a lower serum level and potentially a reduction in efficacy.
DB13944
Azosemide may increase the excretion rate of Testosterone enanthate which could result in a lower serum level and potentially a reduction in efficacy.
DB13946
Azosemide may increase the excretion rate of Testosterone undecanoate which could result in a lower serum level and potentially a reduction in efficacy.
DB13952
Azosemide may increase the excretion rate of Estradiol acetate which could result in a lower serum level and potentially a reduction in efficacy.
DB13954
Azosemide may increase the excretion rate of Estradiol cypionate which could result in a lower serum level and potentially a reduction in efficacy.
DB13955
Azosemide may increase the excretion rate of Estradiol dienanthate which could result in a lower serum level and potentially a reduction in efficacy.
DB13956
Azosemide may increase the excretion rate of Estradiol valerate which could result in a lower serum level and potentially a reduction in efficacy.
DB13967
Azosemide may increase the excretion rate of Patent Blue which could result in a lower serum level and potentially a reduction in efficacy.
DB14007
Azosemide may increase the excretion rate of Pentetic acid which could result in a lower serum level and potentially a reduction in efficacy.
DB14126
Azosemide may increase the excretion rate of Tenofovir which could result in a lower serum level and potentially a reduction in efficacy.
DB14526
Azosemide may increase the excretion rate of Chromic citrate which could result in a lower serum level and potentially a reduction in efficacy.
DB14527
Azosemide may increase the excretion rate of Chromic nitrate which could result in a lower serum level and potentially a reduction in efficacy.
DB14528
Azosemide may increase the excretion rate of Chromium gluconate which could result in a lower serum level and potentially a reduction in efficacy.
DB14529
Azosemide may increase the excretion rate of Chromium nicotinate which could result in a lower serum level and potentially a reduction in efficacy.
DB14530
Azosemide may increase the excretion rate of Chromous sulfate which could result in a lower serum level and potentially a reduction in efficacy.
DB14754
Azosemide may increase the excretion rate of Solriamfetol which could result in a lower serum level and potentially a reduction in efficacy.
DB01438
Azosemide may increase the excretion rate of Phenazopyridine which could result in a lower serum level and potentially a reduction in efficacy.
DB06815
Azosemide may increase the excretion rate of Pyrithione which could result in a lower serum level and potentially a reduction in efficacy.
DB11121
Azosemide may increase the excretion rate of Chloroxylenol which could result in a lower serum level and potentially a reduction in efficacy.
DB11085
Azosemide may increase the excretion rate of Resorcinol which could result in a lower serum level and potentially a reduction in efficacy.
DB11090
Azosemide may increase the excretion rate of Potassium nitrate which could result in a lower serum level and potentially a reduction in efficacy.
DB14498
Azosemide may increase the excretion rate of Potassium acetate which could result in a lower serum level and potentially a reduction in efficacy.
DB15593
Azosemide may increase the excretion rate of Golodirsen which could result in a lower serum level and potentially a reduction in efficacy.
DB13987
Azosemide may increase the excretion rate of Strontium chloride which could result in a lower serum level and potentially a reduction in efficacy.
DB01345
Azosemide may increase the excretion rate of Potassium cation which could result in a lower serum level and potentially a reduction in efficacy.
DB04890
Azosemide may increase the excretion rate of Bepotastine which could result in a lower serum level and potentially a reduction in efficacy.
DB01356
Azosemide may increase the excretion rate of Lithium cation which could result in a lower serum level and potentially a reduction in efficacy.
DB04930
Azosemide may increase the excretion rate of Permethrin which could result in a lower serum level and potentially a reduction in efficacy.
DB06707
The risk or severity of Cardiac Arrhythmia can be increased when Levonordefrin is combined with Azosemide.
DB12927
The risk or severity of Cardiac Arrhythmia can be increased when Theodrenaline is combined with Azosemide.
DB13917
The risk or severity of Cardiac Arrhythmia can be increased when Deoxyepinephrine is combined with Azosemide.
DB01364
The risk or severity of Cardiac Arrhythmia can be increased when Ephedrine is combined with Azosemide.
DB00375
Colestipol can cause a decrease in the absorption of Azosemide resulting in a reduced serum concentration and potentially a decrease in efficacy.
DB00658
Sevelamer can cause a decrease in the absorption of Azosemide resulting in a reduced serum concentration and potentially a decrease in efficacy.
DB00930
Colesevelam can cause a decrease in the absorption of Azosemide resulting in a reduced serum concentration and potentially a decrease in efficacy.
DB01432
Cholestyramine can cause a decrease in the absorption of Azosemide resulting in a reduced serum concentration and potentially a decrease in efficacy.
DB00193
The therapeutic efficacy of Azosemide can be decreased when used in combination with Tramadol.
DB00295
The therapeutic efficacy of Azosemide can be decreased when used in combination with Morphine.
DB00318
The therapeutic efficacy of Azosemide can be decreased when used in combination with Codeine.
DB00327
The therapeutic efficacy of Azosemide can be decreased when used in combination with Hydromorphone.
DB00333
The therapeutic efficacy of Azosemide can be decreased when used in combination with Methadone.
DB00454
The therapeutic efficacy of Azosemide can be decreased when used in combination with Meperidine.
DB00497
The therapeutic efficacy of Azosemide can be decreased when used in combination with Oxycodone.
DB00611
The therapeutic efficacy of Azosemide can be decreased when used in combination with Butorphanol.
DB00647
The therapeutic efficacy of Azosemide can be decreased when used in combination with Dextropropoxyphene.
DB00652
The therapeutic efficacy of Azosemide can be decreased when used in combination with Pentazocine.
DB00704
The therapeutic efficacy of Azosemide can be decreased when used in combination with Naltrexone.
DB00708
The therapeutic efficacy of Azosemide can be decreased when used in combination with Sufentanil.
DB00802
The therapeutic efficacy of Azosemide can be decreased when used in combination with Alfentanil.
DB00813
The therapeutic efficacy of Azosemide can be decreased when used in combination with Fentanyl.
DB00844
The therapeutic efficacy of Azosemide can be decreased when used in combination with Nalbuphine.
DB00854
The therapeutic efficacy of Azosemide can be decreased when used in combination with Levorphanol.
DB00899
The therapeutic efficacy of Azosemide can be decreased when used in combination with Remifentanil.
DB00921
The therapeutic efficacy of Azosemide can be decreased when used in combination with Buprenorphine.
DB00956
The therapeutic efficacy of Azosemide can be decreased when used in combination with Hydrocodone.
DB01081
The therapeutic efficacy of Azosemide can be decreased when used in combination with Diphenoxylate.
DB01192
The therapeutic efficacy of Azosemide can be decreased when used in combination with Oxymorphone.
DB01209
The therapeutic efficacy of Azosemide can be decreased when used in combination with Dezocine.
DB01227
The therapeutic efficacy of Azosemide can be decreased when used in combination with Levacetylmethadol.
DB01433
The therapeutic efficacy of Azosemide can be decreased when used in combination with Methadyl acetate.
DB01450
The therapeutic efficacy of Azosemide can be decreased when used in combination with Dihydroetorphine.
DB01452
The therapeutic efficacy of Azosemide can be decreased when used in combination with Diamorphine.
DB01459
The therapeutic efficacy of Azosemide can be decreased when used in combination with Bezitramide.
DB01466
The therapeutic efficacy of Azosemide can be decreased when used in combination with Ethylmorphine.
DB01497
The therapeutic efficacy of Azosemide can be decreased when used in combination with Etorphine.
DB01529
The therapeutic efficacy of Azosemide can be decreased when used in combination with Dextromoramide.
DB01531
The therapeutic efficacy of Azosemide can be decreased when used in combination with Desomorphine.
DB01535
The therapeutic efficacy of Azosemide can be decreased when used in combination with Carfentanil.
DB01551
The therapeutic efficacy of Azosemide can be decreased when used in combination with Dihydrocodeine.
DB01555
The therapeutic efficacy of Azosemide can be decreased when used in combination with Alphacetylmethadol.
DB01565
The therapeutic efficacy of Azosemide can be decreased when used in combination with Dihydromorphine.
DB06204
The therapeutic efficacy of Azosemide can be decreased when used in combination with Tapentadol.
DB06738
The therapeutic efficacy of Azosemide can be decreased when used in combination with Ketobemidone.
DB08861
The therapeutic efficacy of Azosemide can be decreased when used in combination with DPDPE.
DB09174
The therapeutic efficacy of Azosemide can be decreased when used in combination with Lofentanil.
DB09272
The therapeutic efficacy of Azosemide can be decreased when used in combination with Eluxadoline.
DB11130
The therapeutic efficacy of Azosemide can be decreased when used in combination with Opium.
DB11609
The therapeutic efficacy of Azosemide can be decreased when used in combination with Normethadone.
DB12492
The therapeutic efficacy of Azosemide can be decreased when used in combination with Piritramide.
DB13160
The therapeutic efficacy of Azosemide can be decreased when used in combination with Alphaprodine.
DB13454
The therapeutic efficacy of Azosemide can be decreased when used in combination with Nicomorphine.
DB13478
The therapeutic efficacy of Azosemide can be decreased when used in combination with Meptazinol.
DB13605
The therapeutic efficacy of Azosemide can be decreased when used in combination with Phenoperidine.
DB13606
The therapeutic efficacy of Azosemide can be decreased when used in combination with Phenazocine.
DB13787
The therapeutic efficacy of Azosemide can be decreased when used in combination with Tilidine.
DB15360
The therapeutic efficacy of Azosemide can be decreased when used in combination with Carfentanil, C-11.
DB15465
The therapeutic efficacy of Azosemide can be decreased when used in combination with Benzhydrocodone.
DB00945
Acetylsalicylic acid may decrease the excretion rate of Azosemide which could result in a higher serum level.
DB00814
The therapeutic efficacy of Azosemide can be decreased when used in combination with Meloxicam.
DB14513
The serum concentration of Magnesium can be decreased when it is combined with Azosemide.
DB01053
Azosemide may decrease the excretion rate of Benzylpenicillin which could result in a higher serum level.
DB06283
The risk or severity of CNS depression can be increased when Azosemide is combined with Ziconotide.
DB09038
Azosemide may increase the diuretic activities of Empagliflozin.
DB14881
The therapeutic efficacy of Azosemide can be decreased when used in combination with Oliceridine.

序列

实验性质

外部标识符

resource：ChEBI
identifier：31248
resource：PubChem Compound
identifier：2273
resource：PubChem Substance
identifier：347827814
resource：ChemSpider
identifier：2186
resource：Wikipedia
identifier：Azosemide
resource：ChEMBL
identifier：CHEMBL1097235
resource：ZINC
identifier：ZINC000005843546
resource：RxCUI
identifier：18651

外部链接

路径

目标

酶

载体

运输工具

药物反应

效应

不良反应